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CLARIFICATION OF COMMONLY USED TERMS 
 
 
Nodal domains – include the node, paranode, and juxtaparanode 
 
 




Excitable nodal domain – the voltage-gated ion channel-filled node region of the 
heminode, axonal node, and ganglion node 
 
 
Onset of hearing in the mouse – the time when the ear canal naturally opens and 



































 The auditory nerve (AN) is an integral part of the auditory system and 
without it, we cannot hear sound. Glial cells insulate type I spiral ganglion neurons 
(SGNs) with myelin sheaths, which are protective and constrain electrical signal 
within SGNs, facilitating propagation. Formation of excitable nodal domains 
containing clusters of voltage-gated ion channels in unmyelinated gaps along 
axons also allow for rapid saltatory conduction. Sensorineural hearing loss is 
commonly attributed to loss of synaptic connections between the AN fibers and 
hair cells, hair cell loss, or SGN death. Primary glial dysfunction in the AN is not as 
well-studied. Demyelinating diseases such as Guillain-Barre and Charcot-Marie-
Tooth, characterized by myelin and nodal abnormalities, result in reduced nerve 
function manifesting into muscle weakness, sensational changes, and neuropathy. 
In this dissertation, we identified for the first time three types of excitable nodal 
domains in the AN and how these nodal structures form/refine during postnatal 
cochlear development. Our results reveal that maturation of the nodal domains 
contributes to gain in hearing function. In addition, our data demonstrate that 
dysregulation of glial function and dysmyelination after noise in young adult AN is 
partly responsible for noise-induced hearing loss. Lastly, we determined that 
primary glial dysfunction in AN development via knockout of myelination-regulator 
Quaking results in chronic dysmyelination and abnormal nodal structure formation 
leading to slower conduction, dyssynchronous AN firing, and hearing loss.  
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1.1 The neural aspects of the auditory nerve 
 
 
1.1.1 The spiral ganglion neurons 
 The mammalian auditory nerve (AN) is composed of thousands of 
neurons, numbering at approximately 8000 in mice and 30000 in humans1,2. The 
neurons are divided into two types – the type I and type II spiral ganglion neurons 
(SGN). The type I SGNs are bipolar neurons which make up ~90-95% of the AN 
and have their axons myelinated by Schwann cells (SC) and their somata 
myelinated by satellite glial cells (SGC). The type II SGNs, which make up the 
remaining AN population, are monopolar, unmyelinated, and smaller in size 
compared to the type I SGNs. The SGN cell bodies reside in the bony labyrinth of 
the cochlea, termed Rosenthal’s canal (RC), and their peripheral dendrites pass 
through the shelf of this labyrinth, termed osseous spiral lamina (OSL). The 
dendrites pass through narrow openings, termed habenula perforata (habenula 
or hab), to innervate the sensory hair cells (HC) in the organ of Corti on top of the 
basilar membrane. The central processes enter the central modiolus, which the 
bony labyrinth coils around, and are organized into a nerve bundle which leaves 







Figure 1.1.1: Schematic of the auditory nerve 
The figure shows the afferent neurons of the auditory nerve (AN) connecting to 
the hair cells (HCs). Type I spiral ganglion neurons (SGNs) are myelinated and 
connect to the inner HCs (IHC) and type II SGNs are unmyelinated and connect 
to the outer HCs (OHC). They cell bodies or soma of the SGNs reside in 
Rosenthal’s canal (RC) and their peripheral afferents pass through the osseous 
spiral lamina (OSL), and through small holes in the habenula to connect to the 
HCs. To pass through the habenula, type I SGNs demyelinate; forming the 
heminodes/axon initial segments. Type I SGNs are myelinated by Schwann cells 











The type I SGNs innervate the inner HCs, and together, they are responsible 
for sensing sound stimulus and encoding its properties into electrical impulses to 
be relayed to the central auditory pathway. The type I SGNs are the main 
conductors of sound information in the peripheral auditory system. The outer  
HCs, by their own mechanical function, are known to amplify sound waves to 
increase sensitivity and frequency selectivity of the inner HCs3. Therefore, the 
type II SGNs that innervate these outer HCs may not have much to do with 
encoding of sound, and their function is less clear than their type I counterparts. 
In comparison with type I SGNs in response to stimulus, type IIs have slower 
accommodation (it takes a longer time for stimulus to be translated into action 
potentials (AP)), lower AP thresholds, and prolonged response to depolarization4. 
Recent studies have suggested that these type II fibers, which have similar 
properties to C type pain fibers in the nervous system, are playing a role in 
“auditory nociception” after loud noise exposure, via their trauma-induced 
increase in activation5,6.  
 
1.1.2 Tonotopic arrangement and frequency- and intensity-based activity of 
the SGNs 
The SGNs and HCs follow a tonotopic arrangement of the cochlear structure 
– from fibers responding to high frequency at the base, to low frequency at the 
apex. In terms of function, this arrangement is important for the neural encoding 
of the frequency property of a given sound wave. For a pure tone sound stimulus, 
the traveling wave it produces causes the basilar membrane to vibrate at the 
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cochlear tonotopic location of that pure tone’s frequency. Each fiber on the 
tonotopic arrangement is most sensitive and has the lowest threshold of 
response to one characteristic frequency (CF)7. They do respond to frequency 
stimuli close to their CF, but the stimuli would need to be stronger to cross a 
higher threshold level of response. Damaged or degenerated fibers at a certain 
location will no longer be able to encode response for sounds stimulating that 
frequency, leading to loss of information. 
One type I SGN synapses with one inner HC, but one IHC can be innervated 
by multiple type I SGNs. Type I SGNs can be further divided subtypes which 
differ in their spiking properties, even if they innervate the same inner HC. When 
activity of single neurons were recorded in relative absence of sound, they 
showed different spontaneous rates (SR) of activity8,9. High-SR fibers have lower 
thresholds of excitation, while low-SR fibers have higher thresholds of excitation. 
Therefore, at the lowest audible threshold of sound, it is likely that only the high-
SR fibers are contributing to the AN compound action potential (CAP). The high-
SR fibers tend to innervate the pillar side (towards the periphery of the cochlea) 
and the low-SR fibers innervate the modiolar side (towards the center of the 
cochlea) of the inner HCs. The high-SR fibers tend to be larger and have more 
mitochondria than their thinner low-SR counterparts10. The synapse region and 
number of synaptic vesicles are also increased on the side of the HC where the 
low-SR fibers synapse11, which may help increase the fibers’ activity. Different 
firing properties of the type I SGNs are thought to increase the dynamic range of 


















Figure 1.1.3: Auditory brainstem response test waveforms 
Example of auditory brainstem responses (ABRs) evoked by stimuli given at the 
11.3kHz frequency with decreasing levels of intensity in decibels (dB). The black 
arrowhead indicates the wave I action potential (AP) response of the AN. The 
black arrow indicates the threshold, which is the lowest level of visible response 








1.1.3 Auditory brainstem response and neuropathy: Making sense of 
stimulus-based auditory nerve activity 
 The auditory brainstem response (ABR) test is a simple method that 
allows for analysis of stimulus-based AN response. Electrodes placed on the 
animal record the generated responses from the peripheral AN (Wave I) and at 
the level of the brainstem from the very proximal AN close to the cochlear 
nucleus to the lateral lemniscus (Wave II-V) (Figure 1.1.3). Although very useful 
and easy to perform, ABR testing is not the perfect test for AN activity because 
the evoked responses may also encompass activity of the HCs. Wave I 
represents the CAP evoked by the AN. The latency of the onset of Wave I can 
indicate how soon the fibers are activated and how fast they can fire. It would be 
expected that the high-SR fibers are the main contributors of activity at the onset 
of latency. Longer latencies of firing could indicate slower conduction velocity of 
the AN. The peak amplitude indicates the magnitude of response and can 
suggest in part the synchrony of firing of the fibers. Even though the CAP is a 
summed response, the width of the wave should indicate information on the firing 
activities of the various fibers. A shorter width could also suggest synchrony, and 
fibers contributing to the tail end of the width would be indicative of their slower 
conduction and higher thresholds of response. Threshold is another important 
measurement, as it indicates the lowest intensity level of response evoked from 
the fibers by a given stimulus. 
Subjects with sensorineural hearing loss due to loss of HCs or SGNs 
usually have higher thresholds compared to subjects with normal hearing. 
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However, it is entirely possible for subjects to have “normal” thresholds 
compared to their healthier counterparts, but still have hearing impairment. 
Recent studies have termed this as “hidden hearing loss (HHL),” and is 
characteristic of having normal thresholds, but with decreased amplitudes 
compared to normal subjects at suprathreshold responses12. This suggests that 
there is no gross loss of HCs or SGNs, but that there is still some form of 
causative neurodegeneration present. Recent studies have shown that 
degeneration of synapses or heminodes of the SGN afferents can be implicated 
with causing HHL. A study by Kujawa and Liberman has shown that the 
permanent decrease of suprathreshold amplitude responses, even after 
threshold response has recovered to normal after noise-exposure, is due to 
synaptopathy of the SGN afferents and not loss of HCs13. The disruption of the 
heminodal organization may also be a cause of HHL14. The heminode is the 
unmyelinated portion of the SGN axon as it crosses the habenula to innervate 
the HC, and it is myelinated on its side that is proximal to the soma by a SC. The 
heminode is an excitable nodal domain that is said to be the site of action 
potential generation in the SGN15, akin to the axon initial segment at the axon 
hillock of multipolar neurons. This is a very interesting finding because it 
highlights the importance of proper maintenance and function of auditory glia 
















Figure 1.2.1: The auditory nerve glial cells 
A The asterisks indicate the nuclei of myelinating Schwann cells (SCs). The SCs 
enwrap the type I SGN axons with dense myelin lamellae. B The asterisks 
indicate nuclei of myelinating satellite glial cells (SGCs) which surround the type I 
SGN somata with myelin layers that are less dense compared to the Schwann 















1.2  Glial cells and myelination 
 
 
1.2.1 The auditory glial cells  
 There are two types of peripheral glia cells in the cochlea – the satellite 
glia cells (SGC) and the Schwann cells (SC) (Figure 1.2.1). SGCs myelinate the 
somata of Type I SGNs. Besides electrical insulation, SGCs may play a role in 
neuroprotection by providing trophic support to the soma16. Death of the SGCs in 
young-adult mouse ANs by accumulation of sulfatides led to eventual primary 
degeneration of SGNs17. Myelinating SCs form dense, multi-layered myelin 
sheaths around the type I SGN peripheral axons, and one SC myelinates only 
one axon. SCs also myelinate the central processes of SGNs, up until the glial 
transition zone near the tractus spiralis foraminosus, where the nerve fibers 
become myelinated by oligodendrocytes of the central nervous system18. The 
compression of each layer of the multi-layered myelin sheath gives it its 
characteristic dark, electron-dense appearance. Conduction velocities of neurons 
are greatly increased by myelin insulation. Non-myelinating SCs ensheath 
multiple type II SGNs, each with at least one cytoplasm-dense process.  
 
1.2.2 Myelination in the peripheral nervous system during development 
 The SCs of the AN and the rest of the peripheral nervous system (PNS) 
originate from the neural crest, which are able to give rise to both neurons and 
glia, amongst other cell types19. These neural crest cells transition into SC 
precursors at embryonic (E) days 12-13 in mice20. Factors inducing this transition 
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into SC precursors  are not absolutely clear, although studies have shown that 
NRG121 and Notch22 signaling can inhibit neural crest cells from turning into 
neuronal precursors and instead promote gliogenesis. The SC precursors grow 
in close proximity to the axons they will ensheath and their survival is promoted 
by axonal NRG1 neurotrophic factor signaling to erbB receptors expressed on 
the SC precursors23. These then transition into immature SCs by E12-15 in mice 
and are capable of promoting their own survival via autocrine signaling20. These 
immature SCs ensheath groups of axons. Radial sorting will then occur, in which 
an immature SC will ensheath a single axon, usually one that is large in caliber, 
and become pro-myelinating24. The remaining immature SCs ensheathing 
smaller caliber axons, are designated to be mature, non-myelinating SCs. 
Studies suggest that the reason large axons are chosen for myelination is 
because they express more NRG1 type III ligands on their axons, which the erbB 
receptors on the immature SCs can contact, and that these ligands are strongly 
able to induce myelination by activating PI-3kinase pathway in the SCs25. There 
are several signaling factors that promote myelination, and the majority of them 
converge to upregulate the expression of or activate Krox 20, which is 
considered the master transcriptional regulator of myelination and terminal 
differentiation of SCs26,27. Markers of mature myelinating SCs include expression 
of proteins such as P0, MBP, and PMP22, which are structural components of 
compact myelin sheaths27.  
 In the PNS, remyelination of the injured or demyelinated nerve can readily 
occur because of the highly plastic nature of mature SCs. After injury, the mature 
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SCs can degrade and phagocytose their own myelin at the site of injury28. 
Through the actions of the transcription factor c-Jun, the mature SCs can 
transdifferentiate into glia cells specialized for repair and regeneration of the 
axon29. SCs also proliferate in order to provide trophic support and replace dead 
SCs. SCs can then re-differentiate in order to remyelinate the repaired axon, 
possibly through the direction of NRG1 Type I signaling30. However, remyelinated 
fibers tend to have thinner myelin and slower conduction velocities than their 
undamaged counterparts31. 
 Evidence of remyelination and axon regeneration in the AN is not as 
widespread as it is in other peripheral systems. However, some studies do 
suggest that auditory glia cells may play a role in axonal regeneration. Research 
studying dissociated SGNs grown in co-culture with multiple non-neuronal cell 
types from the spiral ganglion region showed that the neurites grown out from the 
SGNs spontaneously associated with auditory glia cells in the culture32. Another 
study has shown that auditory glia cells may dedifferentiate back into an 
immature phenotype, as marked by upregulation of Sox2, and can proliferate 
after induced AN injury33. These studies suggest that signaling from auditory glia 
cells could help promote regeneration of SGNs and that the glia cells also play a 












Figure 1.3.1: Schematic of a node of Ranvier and flanking segments  
The node of Ranvier is the unmyelinated gap between myelin sheaths created by 
two separate SCs. The nodal axolemma (i.e., excitable nodal domain) is filled 
with voltage-gated sodium channels (VGSCs) that are responsible for AP 
regeneration. Thick, cytoplasm-filled SC processes may extend over the node. 
The paranodal region is where the myelin lamellae terminate (i.e. terminal myelin 
loop heads) and form axoglial connections with the paranodal axolemma. This 
physical barrier acts to separate the VGSCs in the node from the voltage-gated 
potassium channels in the juxtaparanode (VGKC). The VGKCs are responsible 
for repolarization of the nodal structure and act to reduce hyperexcitability of the 
neuron. Lamellae at the paranodal-juxtaparanodal regions are non-compact, but 










1.3  The nodes of Ranvier and flanking nodal domains 
 
 
1.3.1 The nodes of Ranvier of the PNS 
Formation of myelin sheaths on the axon allows for the creation of 
unmyelinated gaps between opposing myelin sheaths. These naked gaps, 
commonly termed nodes of Ranvier in other neural systems, are the primary site 
of ion exchange across the axonal membrane and cluster voltage-gated sodium 
channels (VGSC) that are necessary for depolarization for the 
generation/regeneration of AP (Figure 1.3.1). When an electrical stimulus is 
strong enough to cross the threshold of excitation, the VGSCs open to allow 
sodium inside the axon, leading to a depolarization event which produces the AP. 
Because of myelin insulation, the electrical signal cannot be lost via diffusion 
across the axolemma and the AP can rapidly propagate forward to the next 
excitable nodal domain to cause another depolarization/AP regeneration. Aside 
from the rapid conduction velocity, myelination also reduces the metabolic cost of 
AP propagation34 and provides structural support which helps allow for larger 
axonal calibers35.   
Clustering of the VGSCs at the node is made possible by complexes 
formed in the node region. Myelinating glia express gliomedin and glial-NrCAM at 
the SC microvilli contacting the node space3637, and complex with Nfasc18638 
and axonal-NrCAM in the nodal axolemma. During development, these proteins 
initiate the formation of the node by recruiting anchoring protein, Ank-G, and 
scaffolding protein, BIV-spectrin, which cluster and stabilize the VGSCs at the 
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node39,40. In addition, complexes forming axoglial junctions between the terminal 
loops from each myelin lamellae and the axolemma at the paranode regions 
flanking the node serve as physical lateral diffusion barriers that help to cluster 
and stabilize the node components41–43. These axoglial complexes are made up 
of glial Nfasc155 and axonal Cntn1 and Caspr. The paranode regions also act to 
physically separate the nodal VGSCs from the juxtaparanodal voltage-gated 
potassium channels (VGKC). In sciatic nerve studies, loss of axoglial 
connections at the paranode can cause the VGKCs and VGSCs to diffuse 
towards each other and lead to lower conduction velocities42,44. These previous 
studies in sciatic nerves have also shown that the nodal and paranodal 
components are required for proper VGSC clustering, because their genetic 
knockout in development or induced loss in adulthood cause loss of/aberrant 
clustering of VGSCs, elongation of the node region, and overall decrease in 
nerve conduction velocity and excitability.  
The juxtaparanodal region is the domain in between the paranode and 
internode and is covered by non-compact myelin lamellae. The VGKCs are 
anchored to the juxtaparanodal axolemma by transmembrane Caspr245,46. The 
clustering of VGKCs by Caspr2 is assisted by the axo-gial cellular adhesion 
molecule Cntn246. These VGKCs assist in repolarization and inhibit aberrant 
repetitive AP firing47. Reduced expression of VGKCs at the juxtaparanode after 
nerve injury is associated with neuronal hyperexcitability48. Studies have shown 
that SCs may be required for normal distribution and localization of VGKCs in the 
juxtparanode after remyelination and that their presence at the juxtaparanodal 
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domain is more dependent on maintenance by SCs compared to presence of the 
less transient VGSCs at the node49. Besides losing electrical insulation along the 
internode and mislocalization of VGSCs and VGKCs across the nodal domains, 
demyelination can lead to uncovering and exposure of VGKCs at the 
juxtaparanodal axolemma, contribute to decreased excitability of the neuron49.  
 
1.3.2 The excitable nodal domains of the auditory nerve 
 In the murine AN, there are three different types of excitable nodal 
domains (Lang Lab unpublished data, 50). There is the heminode, as previously 
mentioned in the preceding sections. Then there is the axonal node, which is 
flanked on both sides by paranode regions myelinated by SCs, and of which 
there is at least one along the peripheral dendrite of the SGN. The exact number 
per dendrite is yet to be determined. Lastly, there is the ganglion node, aptly 
named because they flank the ganglion body on both sides. These are 
myelinated on the axonal side by a SC and the soma side by a SGC. SGC 
paranode axolemma is contacted by much less compact terminal myelin loops 
compared to the SC paranode side (Lang Lab unpublished data). The ganglion 
nodes also tend to have longer gap lengths compared to the axonal nodes (Lang 
Lab unpublished data). As of now, not much is known about the differences in 
depolarization and action potential firing properties of each excitable nodal 
domain, or if the axonal nodes vary in number or location along the SGN 
depending on where the fiber is on the tonotopic map. Any of these variations, if 
they exist, may help contribute in some way to the different characteristics of the 
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fibers along the cochlea. To elucidate some information of the different excitable 
nodal domain AP generation properties, it may be possible to infer some 
information from their VGSC composition densities and gap lengths. Aside from 
the previously stated hearing impairment associated with heminodal disruption, 
elongation of axonal node gaps and dysmyelination at the paranodes after 
acoustic overexposure are also correlated with hearing loss51. This loss of 
function manifested from the decreased conduction velocity and conduction block 
of the auditory fibers, possibly because of the abnormal nodes. These recent 
findings in the cochlea have helped highlight the contribution of the understudied 
excitable nodal domains of the AN to hearing function.  
 
1.4 The Quaking RNA binding proteins as regulators of myelination and 
paranodal maintenance 
 Indication of the role of the quaking gene (qkI) in myelination was first 
realized through its spontaneous mutation in the DBA/2J mouse strain, which 
manifested in hindlimb tremors seen starting at postnatal day 10 and 
demyelination of the central and peripheral nervous systems52. The 
demyelination and tremors of these quaking viable mice were found to be caused 
by loss of the qkI-6 and qkI-7 isoforms53. The qkI-6 isoform is located in the 
nucleus and cytoplasm of glia cells and qkI-7 is also found in glial cytoplasm. 
These two isoforms are highly expressed during myelination. The third qkI 
isoform, qkI-5, is upregulated during embryogenesis, is located in the nucleus, 
and is not affected in the quaking viable mice, which is why they can survive. 
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This ground-breaking study by Ebersole et.al. has identified the isoforms to differ 
only in their C-terminal regions and classified them as part of the signal 
transduction and activator of RNA (STAR) family of proteins53. These isoforms 
are translated into quaking (QKI) RNA binding proteins (RBP) that each have a 
STAR domain. This domain is made up of the QUA1 region, which is necessary 
for isoform dimerization54, and the KH and QUA2 regions, which are necessary 
for binding to targets with quaking recognition elements (QRE)55. RBPs are 
regulators of glia differentiation, myelination, and paranodal formation through 
post transcriptional modifications of target RNAs. Demyelination in quaking viable 
mice may be due in part to the nuclear retention of MBP RNA by QKI-5 in the 
absence of competitive binding by QKI-6/756. Sole presence of QKI-5 in the 
quaking viable mice is also implicated in aberrant alternative splicing of MAG pre-
mRNA, an important myelin component, leading to an imbalance in MAG protein 
isoform expression57. Addition of QKI-6/7 to SC and neuron co-cultures inhibited 
proliferation of SCs and promoted myelination, possibly through inducing the 
expression of the pro-myelinating factor p27kip158. Recently, a knockout model 
inducing the deletion of all three qkI isoforms has led to the finding that QKI-5 
affects alternative splicing of the nodal/paranodal Nfasc pre-mRNA59. Loss of 
paranodal Nfasc155 expression after the induced knockout led to loss of axo-glial 
connections and dysmyelination at the paranodes. These current findings 









1.5.1 Sensorineural hearing loss 
Hearing impairment (HI) is an epidemic affecting people of all ages world-
wide, with diagnoses ranging from slightly detectable to debilitating, profound 
loss. Approximately 2 to 3 out of 1000 infants screened had congenital hearing 
loss in the United States alone, and that increased to an estimated 6 per 1000 
live births in developing countries60,61. A study conducted on 20-69 year-old men 
and women sampled from different demographics estimated that 27.7 million 
Americans had speech-frequency HI, while 61.1 million had high-frequency HI62. 
The most common cause of HI is sensorineural hearing loss (SNHL). The term 
SNHL roughly describes a two-part condition – the dysfunction or loss of sensory 
hair cells (HC) which are responsible for mechanotransduction of sound into 
electrical impulses, and the dysfunction or loss of the peripheral AN fibers. AN 
afferents synapse with HCs and serve as the first part of the auditory relay and 
processing system that ends with the central auditory cortex. At present, the best 
treatments include the use of sound amplification devices, such as hearing aids, 
and cochlear implants for direct stimulation of intact AN63. These are invaluable 
forms of treatment, especially for those whose suffering is mainly due to sensory 
hair cell damage/loss, but these devices mostly function to patch the problem 





1.5.2 Dymsyelination and hearing loss  
Demyelinating diseases, such as Charcot-Marie-Tooth (CMT) and 
Guillain-Barre Syndrome (GBS) are long known to be associated with HI. The 
Trembler mouse model of CMT present with paranodal dysmyelination which, in 
addition to the dysmyelinated internodes, may contribute to their phenotypic 
tremors64. Some patients with GBS were shown to have antigens against nodal 
and paranodal molecules65. Preservation of proper myelination and nodal 
structures are necessary for retaining and optimizing the physiological function of 
SGNs. At present, there has not been much research on the development of 
electrically excitable nodal domains in the cochlea and gaining such knowledge 
will allow us to have a comparative standard for mutant or disease models.  
Auditory glial cells are important for maintenance and support of SGNs. 
Previous studies in animal models and in humans have shown that SGNs can 
survive after primary sensory HC loss, and can remain with relatively-intact 
somata and central processes, but with degenerated peripheral dendrites66–68. 
SGCs have been shown to play a role in SGN survival, possibly due to 
neuroprotective support via intercellular channels36. Degeneration of SGCs and 
subsequent demyelination of SGN axons in a mouse model of myelin component 
deficiency eventually led to degeneration of SGNs57. Recent studies have shown 
that synaptopathy and SC disruption can be primary causes of hearing loss. The 
ground-breaking publication by Kujawa and Liberman showed that synaptopathy 
can occur after noise exposure and lead to hearing deficits even as the HCs 
remain normal17. Very recently, a study has shown that transient ablation of SCs 
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caused chronic disruption of the heminodes, but had no effect on HCs or 
synapses14. The heminodal disruption was associated with permanent increase 
in latency and decrease in amplitude of AN responses. As well as being 
important for insulating the neurons, myelinating glia express components 
necessary for the initiation of nodal assembly36.  De-regulation of glial function, 
leading to glial dysfunction may disrupt nodal assembly and cause loss of nodal 
structural integrity in addition to dysmyelination. The ensuing loss of structural 
integrity of the nodal domains and myelin may contribute to loss of AN function.  
 
 
1.6 Purpose of this study 
Environmental sound is mechanotransduced by sensory hair cells into 
electrical impulses that are promptly propagated by the AN to the central auditory 
system for processing. SGN peripheral axons are myelinated by SCs and the 
somata are myelinated by SGCs beginning around P2 and with peak myelination 
occurring at around P7. Excitable nodal domains, commonly known as nodes of 
Ranvier, and proper myelination are required for fast conduction of action 
potentials along bipolar type I SGNs of the AN. Preservation of myelin and nodal 
structures are essential for normal auditory response, and understanding their 
postnatal development in the AN would be an important step for conceiving 
gene-based therapeutic approaches to hearing loss. The roles of abnormalities in 
myelination by AN glial cells and nodal segments of the AN in sensorineural 
hearing loss are understudied. With our research, we will take the opportunity to 
study qkI and its role in regulating AN myelination. With this project, we will 
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address the questions of 1) how the nodal domains normally develop in the AN 
before and after hearing onset, and if auditory glial dysfunction can lead to 
dysmyelination and abnormal nodal assembly resulting in hearing deficits 2) after 
noise injury and 3) during AN development. Our overarching goal is to determine 
the contribution of normal nodal structures to hearing maturation in development 












































2.1.1 Vivarium and parameters for use 
Mice, unless specified otherwise, were bred and kept in a low-noise 
environment at the Medical University of South Carolina’s (MUSC) Animal 
Research Facility. All aspects of animal research were conducted in accordance 
with the guidelines of the Institutional Animal Care and Use Committee of at 
MUSC. All mice received food and water ad libitum. The animal rooms were 
maintained on a 12-hr light/dark cycle. Subjects with signs of external ear canal 
and middle ear obstruction or middle ear infection were excluded. Whenever 
possible, mice of either sex were used for the studies.  
 
2.1.2 Normal hearing and noise studies 
The CBA/CaJ mouse strain is commonly used for normal hearing studies 
due to their lack of genetic mutations related to hearing and their ability to age 
without progressive hearing loss69. The CBA/CaJ mice were purchased from the 
Jackson Laboratories (Bar Harbor, ME). Postnatal (P) mice ages P0, 3, 7, 10, 14, 
21, and 1-month-old were used for the developmental studies. Young-adult 








2.1.3.1 Diminuendo  
The Diminuendo (Dmdo) mouse strain, with an N-ethyl-N-nitrosourea 
(ENU) induced point mutation that leads to immature stereocilia and hair cell 
development, were acquired from the lab of Dr. Karen P. Steel and were also 
bred and kept at MUSC70. These mice were kept in the C3HeB/FeJ background 
strain. Dmdo pups were genotyped to select for homozygous (Dmdo/Dmdo) 
animals that are characterized to be profoundly deaf at birth71, and their wildtype 




The QKIFL/FL;PLPCreERT model59 was produced by crossing QKIFL/FL, which 
has loxP sites flanking exon 2 of qkI, with PLP-CreERT 72.  This mutation model 
was used to knockout the qkI isoforms 5, 6, and 7, which encode the QKI RBPs 
5, 6, and 7 respectively. With the PLP-CreERT cross, the knockout of qkI occurs 
in Plp1-expressing cells, which in the AN are the auditory nerve glial cells. These 
mice were kept in the C57BL/6J background strain. Knockout of qkI was induced 
via intraperitioneal injections of 10mg/ml 4-hydroxytamoxifen (TAM) diluted in 
corn oil. A portion of the studies using young-adult QKIFL/FL;PLPCreERT model were 
performed in the Lady Davis Institute for Medical Research Small Animal 
Research Core at McGill University in Montreal, Quebec, Canada. The 
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collaborative research at McGill University were conducted in accordance with 
the McGill University guidelines set by the Canadian Council on Animal Care. For 
the postnatal Quaking studies, the QKIFL/FL and PLP-CreERT mice lines were 
imported from the Richard Lab at McGill University to MUSC.  
To establish the line at MUSC, the QKIFL/FL mouse was bred with C57BL/6J to 
obtain QKIFL/- offspring. Heterozygous QKIFL/- mice were mated together to 
produce homozygous QKIFL/FL. Homozygous QKIFL/FL breeder pairs were used to 
maintain the Quaking mouse line. The PLP-CreERT mouse was bred with 
C57BL/6J to obtain offspring hemizygous for PLP-CreERT and to maintain the 
mouse PLP-CreERT mouse line. Hemizygous PLP-CreERT were then bred with 
homozygous QKIFL/FL mice to produce QKIFL/-;PLPCreERT offspring. These were then 
mated to with QKIFL/FL mice to obtain the QKIFL/FL;PLPCreERT pups to be used for the 
conditional Quaking knockout (i.e., QKI-KO mice). For these studies, either 
QKIFL/FL or QKIFL/- littermate mice negative for the CreERT were used as controls 
(i.e., QKI-Ctrl mice). Protein expression analyses from our collaborator59 and our 
own experimental results on the control mice showed no significant difference 
between the homozygous and heterozygous flox.  
 
2.1.3.3 Genotyping 
Experiment-appropriate Diminuendo and Quaking pups were selected via 
genotyping. DNA was extracted from tail clippings from each mouse either by 
using the Gentra Puregene Mouse Tail Kit (Qiagen, Germantown, MD) and the 
associated manufacturer’s instructions or via the quick genotyping method which 
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consists of extraction by hot sodium hydroxide and tris as described by Truett 
et.al., 200073. The extracted DNA was then used to amplify the identifying, target 
sequence via polymerase chain reaction (PCR) (see Table 2.1.3.3 for primers 
used).  
 The amplified sequence from the Diminuendo mice shows up as one band 
at 224bp and the band cannot indicate if the sample came from a Dmdo/Dmdo or 
Dmdo/+ mouse. To determine the genotype, the samples were sent out to 
Genewiz (South Plainfield, NJ) for sequencing. From the sequences, 
homozygous mice can be identified by the A to T mutation in the mir-96 seed 
region70.  
 To select for QKI-KO versus littermate QKI-Ctrl, the PCR products were 
run on 2% agarose gels. Amplification for the Cre and QKI-2lox sequence were 
performed on each sample. We searched for the single Cre band present at 
~100bp. For the QKI-2lox amplification, we searched for bands at 309bp and 
191bp. A single band at 309bp is indicative of homozygous QKIFL/FL while a 
single bad at 191bp is indicative of a flox null mouse. Bands at both 309bp and 
191bp is indicative of a heterozygous QKIFL/- mouse. Due to our breeding 
scheme, we conclude that our QKIFL/FL;PLPCreERT mice should be hemizygous for 
PLP-CreERT, since our original PLP-CreERT breeding pair consisted of a PLP-
CreERT mouse and a C57BL/6J mouse.  
  





Table 2.1.3.3: Primer sequences used for genotyping 
Primer Sequence 
Dmdo Forward AGACCTCCTCTGCTCCTTCC 
Dmdo Reverse CTCCTCACCCAGCAGTAAGC 
Cre Forward GCGGTCTGGCAGTAAAAACTATC 
Cre Reverse GTGAAACAGCATTGCTGTCACTT 
QKI-2lox Forward ACAGAGGCTTTTCCTGACCA 





















2.2.1 Auditory brainstem response 
For each auditory function measurement, animals were anesthetized via an 
intraperitoneal injection of 20 mg/kg xylazine and 100 mg/kg ketamine cocktail. 
ABRs were performed in a sound-isolation booth with the lights turned off. Each 
ABR equipment was professionally calibrated before use, and sound stimuli were 
delivered into the ear canal via a 10mm long, 3-5mm diameter tube. Unless 
otherwise stated, ABR measurements were acquired via Tucker Davis 
Technologies (TDT) equipment System III (Tucker Davis Technologies, 
Gainsville, FL) and processed via SigGen software package (Version 4.4.1) 
following the Lang Lab protocol used in previous studies74.  For postnatal and 
young-adult CBA/CaJ mice, stimuli were evoked at 4, 5.6, 11.3, 16, 22.6, 32, 40, 
and 45.2 kHz frequencies. The stimuli consisted of 5ms-duration tone pips with 
cos2 rise/fall times of 0.5ms and were delivered 31 times/s with a period of 
32.2581ms. Responses were collected from 90 to 10dB SPL sound intensity 
levels, with each succeeding level being reduced by 5dB steps. Results for each 
mouse tested were analyzed for wave I threshold. 
 
2.2.2 Continuous ABR method to calculate Phase Locking Value (Intertrial 
Coherence) and other metrics of wave I  
ABR activity was recorded continuously using TDT OpenEx. ABRs were 
evoked at 1.1ms-duration pure tone at 11.3kHz frequency with cos2 rise/fall 
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times of 0.55ms. Stimuli were presented at a rate of 21 times/s with a period of 
47.619ms. Data was epoched offline (-2 10ms). Time frequency analysis was 
used to estimate the mean Phase Locking Value (PLV) of wave I via EEGlab. 
Estimation of the PLV aims to measure the synchrony of AN firing across a given 
number of trials (i.e., intertrial coherence). Peak amplitude and peak latency were 
obtained from average responses via ERPlab. This method was adapted for use 
in mice from methods used by the Harris Lab in their human studies75.  
 




2.3.1 Cochlear nerve tissue collection and total RNA isolation 
 
Cochleas from young-adult noise-exposed, non-noise-exposed controls, 
and postnatal CBA/CaJ mice were collected at their designated end-points for 
RNA isolation.  Microdissections were performed to isolate the whole AN from 
the rest of the cochlear structures, taking care to preserve peripheral fibers and 
to exclude the components of the organ of Corti, vestibular system, and lateral 
wall. Each individual sample consisted of total RNA from both ANs per mouse.  
Purification of total RNA from the samples required the use of the miRNeasy Mini 
Kit (Qiagen Inc, Germantown, MD) and the manufacturer’s instructions were 
followed for the isolation. Contamination of genomic DNA was removed during 
the RNA isolation via genomic DNA binding columns. Quality of the RNA 
products was assessed using the Agilent 2100 Bioanalyzer (Agilent 
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Technologies, Santa Clara, CA). Samples that showed degradation or 
contamination of genomic DNA were excluded from the experiments. 
 
2.3.2 Microarray hybridization  
Procedures for probe preparation, hybridization, and microarray data 
processing were modified from those described previously76. Total RNA 
amounting to 50 ng was converted into biotin-labeled cRNA using the 3’ IVT 
Express Kit (Affymetrix, Santa Clara, CA).  Each group consisted of 2 biological 
replicates. Hybridization to Mouse 430 2.0 GeneChips (Affymetrix) and post 
hybridization washing, staining, and fluorescence scanning were conducted 
using Affymetrix instrumentation following manufacturer recommendations.  
Normalized hybridization data was obtained by Robust Multi-array Average 
(RMA)77 and detection calls obtained by MAS 5.0 using Expression Console 
software (Affymetrix). 
 
2.3.3 RNA sequencing  
Total RNA (50 ng) with RNA integrity numbers (RIN) of 8.9-10 were used 
for the RNA-sequencing (RNA-seq) experiments. Each group consisted of 3 
biological replicates. Library preparation and paired-end next-generation 
sequencing using the Illumina HiSeq2500 was performed by the MUSC 
Genomics Share Resource Core. Data was generated in FASTq format. The 
MUSC Bioninformatics Core used the FASTq datasets to create files of raw 
counts of gene expression and as well as log2 transformed, normalized count 
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files via DeSeq2. For the following experiments, the log2 transformed, 
normalized count datasets were used.  
 
2.3.4 Quantitative PCR   
Detailed descriptions of quantitative PCR (qPCR) experiments for each 
study are included under each chapter. In short, two-step reverse transcription 
qPCR (RT-qPCR) was performed. First, total RNA was converted into cDNA via 
reverse transcription. Then, the resulting cDNA products were used to query for 
expression of genes of interest via qPCR. Depending on the experiment, either 
TaqMan probes (Applied Biosystems) or commercial/custom DNA oligo primers 
paired with SYBR dye chemistry. Each experiment included a no RT control and 
the reactions were performed in technical triplicate with 40 cycles of 2-step 
cycling. Melting curve analyses were also performed after each procedure. The 
melting curve profiles were reviewed to ensure that all amplifications produced 
single and specific products. For our studies, relative expression of target genes 
were measured by either one of two ways. The first quantification protocol 
included preparation of a standard curve from 10-fold serial dilutions of our DNA 
preparations to determine efficiency of amplification and ensure that our 
efficiencies were not suboptimal. Relative expression was then calculated via the 
ΔΔCT method as described78,79. The second quantification method was to use 
the PCR Miner webtool which uses an algorithm to quantify efficiency and cycle 
threshold (CT) values of our genes of interest80. The formula 1/(1+Efficiency)^CT 
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was used to calculate the R0 values. Expression of our genes of interest were 
normalized using tissue-appropriate reference genes.   
 




2.4.1 Immunostaining and confocal imaging 
Immunostaining procedures were modified from previous studies74. At 
each designated time-point, mouse cochleae were collected and immediately 
fixed with 4% paraformaldehyde (PFA) solution in 1x phosphate buffered saline 
(PBS) for 2 hours at room temperature (RT) and decalcified with 0.12M 
ethylenediamine tetraacetic acid (EDTA) at RT for 1-2 days. For mouse cochlear 
section preparations, the cochleae were embedded in Tissue-Tek OCT 
compound and sectioned at thickness of ~10 µm. For whole-mount preparations 
of mouse cochlear tissues, the ANs and attached organs of Corti were isolated 
from the rest of the cochlear structures. Fluorescent tagging of primary 
antibodies were achieved either indirectly using biotinylated secondaries 
conjugated with fluorescent avidin (Vector Labs, Burlingame, CA) or directly 
using Alexa Fluor Dyes (ThermoFisher Scientific, Waltham, MA).  
Counterstaining of nuclei were achieved using propidium iodide (PI), Hoescht, or 
DAPI. Slice and confocal image stacks were collected using a Zeiss LSM 880 
NLO with a ZEN acquisition software (ZEISS United States, Thornwood, NY) or a 
Leica SP5 with an LAS AF acquisition software (Leica Microsystems Inc., Buffalo 
Grove, IL). Image stacks were taken at 0.75µm intervals with image sizes of 
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134.95 µm (x) x 134.95 µm (y) from the Zeiss and 144.72 µm (x) x 144.72 µm (y) 
from the Leica. Images were processed using ZEN 2012 Blue Edition (Carl Zeiss 
Microscopy GmbH), Leica Application Suite X (Version 3.0.2.16120) (Leica 
Microsystems CMS GmbH), and Adobe Photoshop CC (Adobe Systems 
Incorporated). A detailed list of antibodies used is in Table 2.4.1.  
 
 
2.4.2 Identification of nodal structures and measurement of excitable nodal 
domain lengths 
Excitable nodal domains were marked via immunostaining of either anti-
NrCam or anti-Nav1.6. Paranodal domains were marked via immunostaining of 
anti-Cntn1. Node dimension measurements were performed on image stacks 
that were converted to maximum intensity projections. Node of Ranvier 
measurements were acquired using the measurement tool on ZEN. Confocal 
image stacks taken at 0.75µm intervals from 10µm cochlear frozen sections were 
processed into a single-layer maximum intensity projection. Length was 
considered as one end of the NrCAM node marker to the other end (see Figure 
2.4.2). Wholly-intact nodes in the parallel plane were measured to limit possible 
inaccuracies. Node parallelism and wholeness were checked using (1) the 
presence of flanking paranodes, (2) 3D visualization of the tissue section using 






















Figure 2.4.2: Node length measurement 
This figure shows an example of a parallel axonal node that is good for 
measuring (indicated by “Yes”) and an axonal node that is not good for 
measuring (indicated by “No”). The excitable nodal domain is marked by 
immunostaining for anti-Nrcam (red) and the paranodal flanks are marked by 
























2.4.3 Transmission electron microscopy  
 
The tissue preparation and imaging procedures for transmission electron 
microscopy (TEM) were described previously74. Briefly, mice 1 month-old and 
above were anesthetized and tissue was fixed via cardiac perfusion with a 4% 
PFA and 2% glutaraldehyde solution diluted in phosphate buffer. The collected 
cochleae were then further perfused with the fixative solution through the round 
window. Cochleae from mice ≤ P21 were perfused with the fixative 3 times 
through the round window, as the mice were too small for cardiac perfusion. 
The 1 month-old and older cochleae were then kept overnight in the fixative at 
4ºC. The P21 and younger cochlea were kept for 4-7 days in the fixative at 4ºC. 
To image cochlear sections without knife marks and to inhibit destruction of the 
diamond knife used to section cochlea, the samples were kept in EDTA for 2-3 
days for thorough decalcification.  Cochleae were post-fixed using a 1% osmium 
tetroxide and 1.5% ferrocyanide solution for 2 hours in the dark, subsequently 
dehydrated, and then embedded in Epon LX 112 resin.  Semi-thin sections for 
pre-TEM observation of AN orientation were cut at 1 µm thickness and stained 
with toluidine blue. Once a coronal plane for a given cochlear turn could be 
observed, ultra-thin sections at 70nm thickness were cut and stained with uranyl 
acetate and lead citrate and then examined using a JEOL JEM-1010 









2.5 Statistical analyses 
 
Unless otherwise indicated, sample sizes (n) for each quantified 
measurement were a minimum of 3 animals. The n for physiological 
measurements (e.g., amplitude and latency), qPCR studies, and ultrastructural 
observations of type I SGNs (e.g., compactness of myelin and g ratio 
measurements) were based on prior studies74,81. For microarray studies, prior 
analyses of injured mouse AN demonstrated that sample size n = 3 were 
sufficient for robust detection of differentially expressed genes while maintaining 
acceptable (i.e., moderate to low) false discovery rates (FDRs)74. The n for each 
experiment will be indicated in the results or figure legend. Representative 
images from each experimental group for each confocal or TEM study are shown 
in the figures. Distribution of the data was tested using either Shapiro-Wilk or 
Kolmogorov-Smirnov Tests for normality. The appropriate parametric or non-
parametric tests were then used.  Statistical software and packages used in this 
project include DeSeq282, dChip83, Microsoft Excel, R (R project84; version 3.5.2)  

















Table 2.4.1: Antibodies used  
Primary 






MN) AF904 1:200 
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Dyes Host Company Catalog No. Concentration 
Fluorescein 




CA) A-2011 1:100 
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Proper passage of electrical impulses and regulation conduction velocity 
through the AN are necessary for the effectual, precise function of auditory 
system. Apart from the contribution of properly mechanotransducing hair cells 
and maintenance of healthy endocochlear potential by the stria vascularis, 
complete myelination of type I SGNs by SCs and SGCs along with intact 
formation of the unmyelinated nodes of Ranvier along the fibers. Canonical nodal 
structures, which contain clustering molecules binding to voltage-gated ion 
channels (VGICs) responsible for the regeneration of action potentials necessary 
for their saltatory conduction throughout successive nodes of Ranvier, are 
essential for the transmission of stimuli. They are fundamental structures in 
myelinate fibers and because their importance for conduction is fact. Studies 
involving the nodes of Ranvier in the peripheral AN have been somewhat scarce, 
until recently. In the developing mouse AN, the contribution of the nodes of 
Ranvier to the onset of hearing and subsequent maintenance of auditory function 
remain to be fully elucidated. 
Development of the nodes of Ranvier have been previously studied 
extensively in other systems, including the sciatic, brainstem, and optic nerve. 
Multiple interdependent mechanisms of nodal assembly have been found for the 
peripheral nervous system. In short, axonal cellular adhesion molecules (CAMs)  
Page 51 
 
Neurofascin 186 (Nfasc 186) and neuronal-CAM (NrCAM) located at the edge of 
early enwrapping SC processes interact with gliomedin, a transmembrane 
protein located at SC microvilli36,37. Together, these molecules work to cluster 
VGSCs that initially form as heminodes at the bilateral terminal edges of SC 
processes. The CAMs also bind other structural proteins at the node, such as 
anchoring protein Ankyrin G (AnkG) and scaffolding protein BIV-spectrin, which 
help secure the VGICs at the nodal axolemma and buttress the clusters 
respectively39,40. Eventually, the heminodes fuse to form an axonal node of 
Ranvier. In conjunction with nodal formation, transmembrane proteins at the 
axolemma adjacent to the heminode act as axo-glial connecting proteins to 
attach the terminating myelin loops of the SC to the axolemma to form classic 
paranodal loops, which may act as physical barriers to contain nodal proteins 
within the node of Ranvier36,42. 
While there is a wealth of information about nodal formation in other 
nervous systems, nodal studies in the peripheral AN is still in its infancy. A recent 
paper by Kim and Rutherford has shed light on placement and maturation of 
voltage-gated ion channels important for saltatory conduction in the axon initial 
segments and axonal nodes of the cochlea and their importance for the onset of 
hearing50. Further characterization of the structural formation of the nodes of 
Ranvier and the paranodal segments assembled by SCs at the axons and SGCs 
of the SGN somata are still necessary. In this chapter, we characterize the three 
types of nodal structures present in the AN – heminode, axonal node, and 
ganglion node – and their common and distinctive properties. We then show that 
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structural and molecular development and maturation of nodal structures, in 
parallel with myelination of the AN fibers, are important contributors to the onset 
of hearing and maturation of AN function. We also further emphasize their 
functional importance by highlighting nodal structural abnormalities present in the 
early AN development of an animal model of profound hearing loss. 
 
 
3.2 Specific methods 
 
 
3.2.1 Animals used  
 
 CBA/CaJ pups aged P3, 7, 14 and 21 were used for the RNA-seq and RT-
qPCR analyses. The aforementioned age groups, with the addition of P10 and 1 
month-old mice were used for histological analyses, including TEM and node 
length measurements. Pups aged P12 were included in the ABR thresholds 
measurements. Dmdo/Dmdo and +/+ WT control pups aged P14 were used for 
the heminodal clustering comparisons.  
 
 3.2.2. Developmental RNA-seq analyses of node-related genes 
 Normalized, log2 transformed RNA-seq datasets acquired from the FASTq 
files via DeSeq282 from P3, 7, 14, and 21 mice were used. A list of node-related 
genes were compiled using literature39,42 and amiGO85 using the terms “node of 
Ranvier,” “paranode region of axon,” “paranodal junction assembly,” 
“juxtaparanode,” and “internode.” A pairwise comparison of the expression of the 
node-related genes between the age groups of the RNA-seq datasets were 
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performed using dCHIP83. Significant differential expression was defined as p 
<0.05 (Student’s t-test, unpaired, 2-tailed) for at least one pairwise relationship 
among the different postnatal time points. The FDR after 1000 permutations was 
found to be 12.8%.  
 
3.2.3 RT-qPCR 
Total RNA was extracted from the ANs from postnatal CBA/CaJ pups at 
each designated time point. cDNA was produced from the total RNA samples 
amounting to 50ng each via reverse transcription using the QuantiTect Reverse 
Transcription Kit (Qiagen) and according to the manufacturer’s protocol. The 
resulting cDNA products were then assayed for expression of our genes of 
interest and the 18s reference gene via TaqMan probes (Applied Biosystems) 
using a Lightcycler 480 (Roche Diagnostics).  Relative expression was calculated 
via the standard curve/ΔΔCT method and normalized with the 18s reference 
gene.  
 
3.3 Results  
 
 
3.3.1 Expression profiles of genes composing nodal structural domains 
exhibit temporal clustering and the onset of node formation in the mouse 
auditory nerve 
 In order to characterize nodal assembly in the mouse AN, we first looked 
at the expression profiles of node related genes in critical developmental time 
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points with relation to myelination and hearing onset. Previous TEM studies done 
in the Lang Lab show that myelination of the type I SGNs starts at around P3 and  
that peak myelination activity occurs at around P7. Literature showed that in 
mice, the onset of hearing occurs at P10-1286, and that further maturation of AN 
function occurs after the ear canal opens and the AN is free to respond to 
external sound stimulus. We therefore chose the time points P3, 7, 14, and 21 for 
our RNA-seq studies to encompass these critical events.  
With our RNA-seq analyses, we found that 39 out of the 42 genes in our 
node-related gene list were significantly differentially expressed (p<0.05, 
Student’s t-test, unpaired, 2-tailed) on at least one pairwise comparison between 
the age groups. After hierarchical clustering analyses of the data, we found that 
the expression profiles of the node-related genes grouped together in 3 
distinguishable temporal-based clusters (Figure 3.3.1 A, Table 3.3.1). Cluster 1 
(P3-P7) is composed of genes important for onset of nodal formation, including 
genes encoding for cell-cell interaction, scaffolding, cellular adhesion and 
extracellular matrix molecules39,87–89. Also present in Cluster 1 is Scn2a1 which 
encodes the voltage gated sodium channel Nav1.2, a marker of immature nodes 
of Ranvier later replaced by Nav1.6 in adult nodes of Ranvier after the onset of 
myelination90. Cluster 2 (P7-P21) is mainly composed of genes involved in onset 
of paranodal junction assembly91 and myelination92–97. Cluster 3 (P14-21) is 
comprised of genes encoding structural proteins of the electrically excitable nodal 
domain40,98,99, and axo-glial connector proteins at the paranode42,100 and 
juxtaparanode45,101. Genes encoding for voltage-gated potassium channels of the 
Page 55 
 
juxtaparanode48,49 and the mature nodal Nav1.6 are also present. This clustering 
of genes indicate that in the mouse AN, the onset of node formation is around 
~P3, with myelination and formation of paranodal domains occurring at around 
P7, and assembly of juxtaparanodes occurring at around ~P14. The up-
regulation of node genes encoding structural proteins of each domain and 
voltage-gated ion channels may indicate that the nodal structure is prepared to 
function for the onset of hearing.  
We validated our findings with qPCR (Figure 3.3.1 B-F) and found similar 
expression levels with the RNA-seq datasets. We validated the presence of 
neuronal-CAM (NrCAM) node protein (Figure 3.3.1 G), which is encoded by the 
gene Nrcam, encodes responsible for signaling for node formation39 using 
immunostaining, since the gene seemed to be present a steady amount during 
the developmental time points as shown by the qPCR analysis. In this 
immunostaining analysis involving NrCAM and neuronal marker NF200, we show 
that NrCAM protein is present very early in the nodes of the mouse AN. The 
node staining as marked by NrCAM was only present in the hook area of the AN, 
which is the basal most point of the AN. This may indicate that nodal assembly 









Figure 3.3.1: Expression profiles of genes composing nodal structural 
domains exhibit temporal clustering 
(A) 39 out of 42 node-related genes were significantly differentially expressed 
between postnatal (P) day 3, 7, 14, and 21 ANs. Significant differential 
expression (p<0.05, Student’s t-test, unpaired) of the genes were found via 
pairwise comparisons between all postnatal days. The FDR for the analysis was 
at 12.8% (1000 permutations). In this heatmap, red indicates up-regulated gene 
expression, white indicates baseline gene expression, and blue indicates down-
regulated gene expression.  Hierarchical clustering analysis by peak expression 
of the genes distinguish 3 clusters (Table 1 lists genes in each cluster). (B-F) 
qPCR experiments validate presence of nodal (B,C), paranodal (D,E), and 
juxtaparanodal (F) genes in another set of P3, 7, and 14 ANs. One-way analyses 
of variance (ANOVAs) with Bonferroni post-test for multiple comparisons were 
performed to show differential expression among the different time points (* = 
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3.3.2 Hearing onset and maturation of AN function and their relation to SGN 
subtype differentiation  
 In order to bridge our molecular findings pertaining to nodal assembly to 
the function of the AN, we completed physiological studies by doing ABR 
measurements on mice aged P12 and P14 at the onset of hearing and shortly 
after, in P21, which is further along development, and in 1M, young-adult mice.  
Figure 3.3.2 A shows thresholds of hearing sensitivity drastically getting better 
from P12-14 and from P14 to P21. The thresholds from P21 and 1M are 
overlapping. Suprathreshold measurements tested at 11.3kHz, which represents 
fibers at the middle turn, are shown in Figure 3.3.2 B-D. Synchrony of AN firing 
across trials (Figure 3.3.2 B) between P14 and P21 are significantly higher at 
80-90dB.  Peak latencies are significantly shorter across all intensity levels 
(Figure 3.3.2 C). Although peak amplitudes are not significantly different 
between P14 and P21, the median response from the mice in the P21 group are 
consistently higher across levels compared to the P14 group. The P21 group 
response is also overall less variable compared to the P14 group. The variability 
in response in the P14 animals may be due to the young age of the animals and 
the rapid changes undergoing in the cochlea at that time.  
 Many events occur in the cochlea during early development, including the 
emergence of the endocochlear potential102, the maturation of the hair cells103, 
and myelination of type I SGNs. One well-studied characteristic of the AN is the 





Figure 3.3.2: Hearing onset and maturation of AN function and their relation 
to SGN subtype differentiation 
(A) Audiogram showing ABR wave I thresholds from P12, P14, P21 and 1M 
mice. N = 7 mice for P12 and P14; n = 5 mice for P21 and 1M. (B-D) shows 
suprathreshold measurements of ABR wave I from P14 and P21 mice at 
11.3kHz. (B) Synchrony of AN firing of P21 mice are significantly better than in 
P14 mice for 80-90dB SPL (Mann-Whitney U Test, n = 8 mice/group). (C) Peak 
latencies are shorter across all shown levels (Mann-Whitney U Test, n = 8 mice 
for P14, n = 4 mice for P21). (D) Peak amplitudes are slightly higher in P21 
animals, but are not significantly different compared to P14 mice (Mann-Whitney 
U Test, n = 8 mice/group). E-J show representative images of different type I 
SGN subtypes in P14 (E-G) versus P21 mice (H-J) as marked by Calb1 (E,H) 
and Calb2 (F,I). The merged images with nuclear counterstain DAPI are shown 
in G,J. For the non-parametric Mann-Whitney u tests, * = p<0.05, ** = p<0.01, *** 






The physiological characterization of these subtypes were completed long ago in 
cats104 and in gerbils9. It was not until recently that molecular markers for the 3 
subtypes were found and that it was revealed that differentiation of the subtypes 
occurred in between the first and third postnatal weeks105–107, and that maturation 
of the subtypes were dependent their expression of their characteristic molecular 
marker. High SR fibers are marked by Calb2, mid SR fibers are marked by 
Calb1, and low SR fibers are marked by either Lypd1 or Pou4f1. In early 
development, the SGNs may express all these markers, while in later 
development, differentiated SGNs would express mainly one marker.   
 In our studies, we used Calb2 to mark high SR fibers and Calb1 to mark 
mid SR fibers (Figure 3.3.2 E-J). Deductive reasoning would lead us to conclude 
that cells negative in both Calb1 and Calb2 are most likely to be low SR fibers. In 
representative images taken from the middle turn of the AN from P14 and P21 
mice, we show that Calb2+ cells, as well as Calb1-/Calb2- cells, are greater in 
P21 compared to P14. This indicates that there are more high and low SR fibers 
in P21 mice compared to P14 mice, and that differentiation of the subtypes was 
occurring in between the P14 and P21 time points. The changing AN fibers post 
hearing onset may affect maturation of AN function and potentially other 






3.3.3 Assembly of nodal and paranodal proteins comprising the axonal and 
ganglion nodes 
 In most literature, the structure most commonly known as the nodes of 
Ranvier is usually thought of as the gap of axolemma nestled between two 
opposing myelin sheaths. This gap is known to be filled with voltage-gated ion 
channels responsible for action potential regeneration. Since we are researching 
the bipolar neurons of the AN in our studies, unlike the multipolar neurons 
popularized by textbooks, we show that these excitable nodal domains come in 
three different types. Two types of excitable nodal domains are the axonal nodes 
and the ganglion nodes. The axonal nodes can be described as the typical node 
of Ranvier, with the unmyelinated gap between two myelin sheaths (Figure 3.3.3 
N).The ganglion nodes of the bipolar type I SGN flank either side of the soma. 
Figure 3.3.3 O shows one of the ganglion nodes on one side of the soma. The 
Cntn1-marked paranode on the SC myelinated side is clearly visible.  The third 
excitable nodal domain is the heminode, which can be found only at the 
habenula underneath the IHC. The heminode will be discussed in greater detail 
later in the chapter.  
 Our immunostaining studies (Figure 3.3.3 A-L) in development show that 
heminodes are only found in the habenular region, axonal nodes are found along 
the axon in the peripheral side of the AN fiber at the OSL and the central side of 
the AN fiber at the Mod, and the ganglion nodes are found in the RC flanking the 
type I SGN somata. At P7, axonal nodes, as marked by NrCAM, are not yet all 
flanked by two paranodes, as marked by Cntn1, and the majority of ganglion 
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nodes do not have Cntn1 reactivity where the SC paranode should be (Figure 
3.3.3 C,D). However, by P10, the axonal nodes have paranodal flanks, and so do 
the ganglion nodes (Figure 3.3.3 G,H). By P14, axonal and ganglion node 
structure are complete, coinciding with the onset of hearing and the cochlea’s 
readiness for external sound stimulus-based responses.  
We measured the axonal (Figure 3.3.3 P-R) and ganglion (Figure 3.3.3 
S-U) node lengths to quantify and characterize how they change from pre-
hearing onset (P7), around the time of hearing onset (P10-14), and after (1M). 
Our data shows that at P7, the axonal node lengths are significantly longer 
compared to P10 and P14 (Figure 3.3.3 P,Q,R). This may be due to the two 
opposing myelin sheaths being further away from each other. As myelination 
continues, the opposing myelin sheaths formed by two SCs get closer and push 
the nodal components in a shorter, smaller area. At P14, the axonal node gap is 
at its shortest for all three turns. By 1M however, the axonal nodes have 
significantly increased in length compared to P14. The mean node length at P14 
was ~1.2-1.4 µm, while at 1M, the mean node length has increased to ~1.9 µm. 
For the ganglion node lengths, the length at 1M was significantly shorter that P14 
in the apical turn (Figure 3.3.3 S). For the middle (Figure 3.3.3 T) and basal 
(Figure 3.3.3 U) turns, the ganglion node length in 1M were significantly shorter 
compared to P7, P10 and P14. Mean ganglion node lengths at P14 were ~3.6-4 








Figure 3.3.3 Assembly of nodal and paranodal proteins comprising the 
axonal and ganglion nodes 
(A-H) The panels show assembly of the nodes, marked by NrCAM in red, and 
paranodes, marked by Cntn1 in green from P7, 10, and 14. A,E,I show the 
heminodes and axonal nodes where they are located at the habenula and OSL, 
respectively. B,F,J show the ganglion nodes which are located in the RC and the 
axonal nodes passing through the RC to the modiolus. C,G,K are enlargements 
of axonal nodes in P7 (C), 10 (G), and 14 (K) found in the OSL. The white arrows 
in C indicate axonal nodes with missing undeveloped paranode flanks and the 
white arrowhead indicates a node completely flanked by two paranodes on either 
side. D,H,L are enlargements of ganglion nodes found in the RC in P7 (D), 10 
(H), and 14 (L). The white arrow in D indicates a ganglion node with no Cntn1-
marked paranodal flank. The white arrowheads in H indicate the paranode flanks 
of the ganglion nodes. M shows a schematic of the axonal node indicating 
elements of the node, paranode, and juxtaparanode. N shows a canonical axonal 
node and O shows a canonical ganglion node in a 1 month-old mouse AN. 
Axonal and ganglion node measurements from P7, 10, P14, and 1M ANs are 
shown in P,Q,R and S,T,U respectively. The measurements are done along the 
three cochlear turns – apical (P,S), middle (Q,T), and basal (R, U). Statistical 
testing for significant differences between the average measurements from each 
time point were completed using one-way ANOVA with Tukey’s multiple 
















The change in axonal and ganglion node lengths between P14 and P21 can be 
explained in part by continuing maturation of myelination. This is especially true 
of the ganglion nodes, which have one flanking SC paranode and one flanking 
SGC paranode. Myelination of the somata by SGCs occurs later compared to 
myelination of the axonal afferents by SCs. Since recent literature and our own 
studies have shown that differentiation of type I SGNs into different subtypes are 
occurring in between P14 and P21, the molecular and structural changes may 
contribute to further maturation of the nodal domains leading to the axonal node 
lengthening and ganglion node shortening that we see.  
 
3.3.4 Node lengths are associated with amplitude growth and decreasing 
latency 
 In order to elucidate the potential relationship between the changing node 
lengths and gain in amplitude between P14 and P21, we performed correlation 
analyses. Since the slope of the amplitude was not significantly different between 
the two age groups (Figure 3.3.4 A), we ruled out “age” as a factor contributing 
to the increased amplitude slopes of the animals in the P21 group compared to 
the animals in the P14 group. We did find that axonal nodes were significantly 
longer and ganglion nodes significantly shorter in the animals in the P21 group 















Figure 3.3.4: Node lengths are associated with amplitude growth and 
decreasing latency 
A Shows the slope of the amplitudes from animals in the P14 group compared to 
those in the P21 group are not significantly different. B and C show that axonal 
nodes lengths are significantly longer and ganglion node lengths are significantly 
shorter for animals in the P21 group compared to those in the P14 group. D The 
correlation analysis shows that as the ganglion node lengths decrease, the slope 
of the amplitude increases. This association between these two variables were 
shown to be strong and significant, with r = -0.5  p = 0.025. E The correlation 
analysis between axonal node length and the slope of the amplitude showed that 
there was no significant correlation between the two variables. The correlation 
analyses show that ganglion node shortening (F) and axonal node elongating (E) 
are indicative of decreasing latencies.  N = 8 animals/group for A-E; n = 8 
animals for P14/ 4 animals for P21 for F-G. Mann Whitney U Test was performed 
in A. Student’s t tests, unpaired, two-tailed were performed for B and C. 
Pearson’s product-moment correlation tests, one-sided, were performed across 


















For our correlation analyses, we compared the node lengths and amplitude 
slopes across groups, since the relationship with the amplitude occurs 
independently of age. Our data in Figure 3.3.4 D and E show that decreasing 
ganglion node lengths, but not increasing axonal node lengths, are correlated 
with amplitude growth. To further emphasize the structure-function relationship 
between node lengths and AN function, we show that shorter ganglion nodes and 
longer axonal nodes are associated with faster conduction velocity. 
We show in Figure 3.3.2 E-J that type I SGN differentiate into the 3 
subtypes between P14 and P21 and we show here that node lengths change 
between P14 and P21. Although gain in amplitude across the levels tested were 
not significant, they were still present. We argue that the reason why the change 
in amplitude between the two groups were not significantly high was because the 




3.3.5 Ultrastructural assembly of axonal nodes and flanking paranodes 
 In order to better characterize nodal domain assembly pre-hearing onset 
and after hearing onset, we analyzed found and analyzed the nodal 






Figure 3.3.5 Ultrastructural assembly of axonal nodes and flanking 
paranodes 
A and B show the nodal and one paranodal domain of a P6 AN fiber. The inset A’ 
highlights the immature organization of the terminal myelin loops at connecting to 
the paranodal axolemma. Black arrows in B indicate terminal myelin loop heads 
connecting migrating from the internode, but not quite reaching the paranodal 
domain. Instead, they are currently at the juxtaparanodal region, which is where 
the dense-compact myelin layer begins to become non-compact, transitioning to 
the paranodal domain. C shows the terminal myelin loop heads connecting to the 
paranode region. A few layers indicated by the black arrowhead are still in the 
juxtaparanode region. D shows the terminal myelin loop heads connecting to the 
axolemma of the paranode similar to the organization seen in 1M as indicated in 
E and the inset in E’. 
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Axonal paranodes are created by the termination of the myelin lamellae from 
myelinating SCs at the paranodal axolemma. At the paranode, the terminating 
lamellae are seen as membrane loops filled with cytoplasm. This loop provides a 
larger surface area for axo-glial connections and glial-glial connections between 
the adjoining lamellae and terminal loops. We show that the myelin loop layers in 
P6 are still migrating to the paranodal domain from the internodal region (Figure 
3.3.5 A,B). The terminal loops are still spaced far apart as shown in Figure 3.3.5 
A’.  In a canonical paranodal region, such as the one shown in Figure 3.3.5 E, 
the terminal myelin loop heads are connected to the paranodal axolemma and 
are juxtaposed closely together with no gaps. The terminal myelin loops and their 
axo-glial connection separate act as physical barriers to separate the VGSCs in 
the node from the VGKCs in the juxtaparanode41,42,49. This axo-glial connection is 
accomplished by proteins such as Cntn1. We show previously in Figure 3.3.3 G 
that the axo-glial protein Cntn1 was fully present in both flanking axonal 
paranodes by P10. However, as we show in Figure 3.3.5 C, the ultrastructural 
connection at the paranode may not be fully complete. We show in Figure 3.3.1 
A that gene encoding axo-glial connector proteins and structural supports are 
upregulated at P14.  By P14, as shown in Figure 3.3.5 D, we found that 










Figure 3.3.6: Ultrastructural assembly of ganglion nodes and satellite cell 
paranodes 
A shows a ganglion node at P14, with an enlargement of the image shown in A’. 
The inset in A’ shows few terminal myelin loop layers of the SGC lamellae 
connecting the SGC paranodal region. Axo-glial connections between the SGC 
lamellae and the SGC paranodal axolemma at P14 are neither distinct nor do the 
terminal loops solidly attach to the axolemma. B and C show ganglion nodes in 
1M AN fibers. Each panel includes an inset highlighting a magnification of the 
boxed region of interest. The insets in B’ and C highlight the connections of 





















3.3.6 Ultrastructural assembly of ganglion nodes and satellite cell 
paranodes 
 
 While the paranodal flank myelinated by SCs show clear organization and 
connection of the terminal myelin loops at the SC paranodal axolemma, the 
paranodal region myelinated by an SGC still show incomplete attachment of the 
SGC lamellae at the paranodal axolemma of the P14 ganglion node (Figure 
3.3.6 A, A’). The SGC lamellae are very few and are loosely, if at all, attached to 
the axolemma (see enlarged region of interest in Figure 3.3.6 A’). In mature 
SGC ganglion nodal structures, as shown in Figure 3.3.6 B,C, the terminal 
myelin loop layers of both SGC and SC myelin are connected to the paranodal 
axolemma. The number of SGC lamellae have increased and the terminal myelin 
loops show distinct connection to the paranodal axolemma (see enlarged region 
of interest in Figure 3.3.6 B’).  
Regardless of age of the AN, these ultrastructural studies also show the 
clear difference between SGC myelination of the soma/ganglion paranode and 
SC myelination of the axon. The myelin lamellae surrounding the soma and 
terminating at the ganglion paranode are less compared to SC lamellae. The 
terminal myelin loop heads, though connected to the axolemma, have much 
space in between the loops and layers, indicating that glial-glial connection of the 
SGC lamellae are less strong compared to SC lamellae. The incompleteness of 
the SGC paranodal structure by P14 compared to the completeness of the SC 
paranodal structure at the same age indicate that maturation of the SGC 
myelination occurs later compared to SC myelination and may also be related to 
SGN subtype differentiation.    
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3.3.7 Completion of heminodal clustering under inner hair cells is 
temporally dependent 
 
The heminodes, also known as the axon initial segment of the type I 
SGNs, are the site of action potential generation for the AN fibers. The peripheral 
afferents begin to unmyelinate at the habenula in order to pass through the 
habenula perforata and connect to the IHCs. Towards the OSL side, the fibers 
are myelinated by SCs, and the heminodes therefore only have one paranodal 
flank. We show that in the AN turns pre-P14, the components of the heminodes, 
as marked by NrCAM and Nav1.6, are still travelling towards the habenula. In the 
basal turn at P7 (Figure 3.3.7 A”), this is less apparent, as more heminodes 
have clustered underneath the IHCs. Still, several heminodes are visibly 
approaching from the OSL region in the basal turn, but even fewer so in the P10 
basal turn (Figure 3.3.7 B”). The number of heminodes approaching the 
habenula from the OSL are even more apparent in the middle turn at P7-P10 
(Figure 3.3.7 A’,B’) and in the apical turn at P7-P14  (Figure 3.3.7 A,B,C). By 
P14, we determined that clustering of heminodes underneath IHCs in mostly 
complete in the basal and middle turns, and in 1M, young-adult ANs, heminodal 
clustering is complete in all turns (Figure 3.3.7 D,D’,D”). These observations 
support our idea that the completion of heminode migration and clustering 














Figure 3.3.7: Completion of heminodal clustering under inner hair cells is 
temporally dependent.  
Heminodal clustering indicated by NrCAM are shown horizontally across time 
points and vertically across AN location from apical, middle, and basal (A-D”). 
Arrowhead in C-C” shows that clustering of the heminodes underneath the IHCs 
at the habenula are complete in all turns by P14 similar to that seen in 1M. 
Heminodal clustering of Nav1.6 is complete in the middle turn by P14 compared 





We show the flanking Cntn1 paranode to visualize the movement of myelination 
and the pushing of nodal components towards the habenula in Figure 3.3.7 F. 
We show that the heminode clustering is complete in the middle turn by P14, 
since the clusters are right under the IHCs, and they are spaced much farther 
apart across the OSL from the first axonal nodes which are clearly marked by 
two flanking paranodes (Figure 3.3.7 H).   
 
 
3.3.8 Disorganization of the heminodes in a model of profound hearing loss  
  
 The homozygous Dmdo/Dmdo mice have an ENU-induced point mutation 
causing immature stereocilia and hair cell formation leading to profound deafness 
at birth70,71.  WT mice have normal hearing comparable to CBA/CaJ, mice while 
Dmdo/Dmdo littermates have no hearing sensitivity at P14 (Lang Lab, 
unpublished data). In this mouse model, the mutation causes the HCs to be 
perpetually immature throughout early development and degenerate in later 
development due to lack of activity. With this lack of activity, we hypothesized 
that since myelination and, to an extent, nodal formation may be driven by in 
spontaneously electrically active hair cells pre-hearing onset, nodal assembly 
may be inhibited or impaired in the Diminuendo mutant model. We show here 
that though we found no significant differences in the axonal and ganglion nodes, 
there is clear disorganization of the heminodal clusters in the Dmdo/Dmdo ANs 














Figure 3.3.8: Disorganization of the heminodes in a model of profound 
hearing loss  
Heminodes as marked by NrCAM in P14 wildtype (+/+) and homozygous 
Diminuendo (Dmdo/Dmdo) cochlear sections. Notice the compactness of 
heminode clusters at the habenulae in all cochlear turns of the WT sections, A, 
A’, A”.  Asterisk and arrowhead denote the less condensed and more 
disorganized heminodal clusters in the apical B and middle B’ turns of the 









The heminodes are further out from the habenula and are spread closer towards 






 With these studies, we present three major findings pertaining to the mouse 
AN. First, we pioneered the characterization of the three different types of excitable 
nodal domains in the mouse AN type I SGNs. Then, we showed that SC and SGC 
myelination of type I SGNs is morphologically different from each other and that 
SGC myelination is slower compared to SC myelination. Lastly, we showed a 
significant structure function relationship between the nodal structures and AN 
function, with longer axonal nodes being associated shortening latencies and 
shorter ganglion nodes being associated with both shortening latencies and 
amplitude growth.  
 Most of the research on nodal domains in the PNS are usually conducted 
in the sciatic nerve due to ease of access/manipulation and because of its relatively 
straight layout (at least when compared to the spiral-shaped AN). Even now, there 
are only a small number of articles involving the nodes in the AN. In this chapter, 
we characterized the three nodes molecularly and ultrastructurally. Clustering of 
node-related gene expression showed up-regulation of these clustered genes in a 
time-dependent manner, indicating three main time points pertaining to the nodal 
structure: 1) onset of formation, 2) complete assembly of structural molecules, and 
3) further maturation. Genes responsible for initiation of the excitable nodal domain 
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formation were found to be up-regulated at P3. Genes responsible for myelination 
and initiation of paranode formation were found to be up-regulated at P7. Genes 
encoding structural proteins of each nodal domain and the voltage-gated ion 
channels were up-regulated at P14, which coincides with the onset of hearing. In 
accordance to the transcriptomic data, we argue that molecular assembly of the 
nodes and paranodes were complete by the onset of hearing at around P14 via 
immunostaining of key structural and functional proteins, nodal NrCAM, paranodal 
Cntn1, and the functional Nav1.6. We show that NrCAM is present in the basal 
hook area as early as P3, which supports its importance as an initiator of nodal 
formation. Multiple studies have shown this CAM to be essential for the initial 
VGSC clustering at in the forming nodes and for maintenance and restriction of the 
VGSC clustering at the nodes36–39. We also highlight the temporal-dependent 
expression of axo-glial connector Cntn1 at each type of ganglion paranode, with 
Cntn1 present in all ganglion paranodes by P14. We conclude that the completion 
of nodal assembly parallels the onset of hearing.  
 We show that maturation of the nodal structures after the onset of hearing 
was possible through our measurements of the axonal and ganglion node lengths. 
For the axonal nodes, we found that axonal node lengths shortened towards 
hearing onset (from P7 to P14) and increased again between P14 to P21/1M. The 
shortening axonal nodes pre-hearing onset may be due to SC myelin still forming. 
We concluded this through our axonal node ultrastructural data which showed the 
dense, compact organization of the myelin lamellae throughout the internodes and 
terminal myelin loop heads strictly at the paranodal region of SC paranodes by 
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P14. The lengthening of the axonal nodes post hearing onset is in parallel with 
functional maturation. Lengthening of the axonal nodes may be due to clustering 
of additional voltage-gated ion channels in the node. The one other paper that 
focused on the nodal domains was the 2016 article by Kim and Rutherford50, in 
which they characterized various VGSC and VGKC protein expression profiles via 
immunostaining in rat ANs around the onset of hearing. They revealed valuable 
information, especially pertaining to the clustering of low-voltage KV1.1 VGKCs at 
the juxtaparanodes, which occurred starting at the time of hearing onset. They also 
showed the additional expression of certain VGKCs in specific nodal domains, 
including the excitable heminodes and nodes, after hearing onset. These findings 
corroborate our own conclusions that even after molecular and structural assembly 
of the nodal domains at P14 around the onset of hearing, maturation of the nodal 
structures continue to occur. 
 The lengthening of axonal nodes post hearing onset may also be due to 
the differentiation of the type I SGNs into the three subtypes which they have 
shown to occur approximately between P14 and P21105–107, as we have also 
validated in this chapter. Single neuron studies from cats108, gerbils9, and mice109 
show that SGN subtypes have distinct morphologies associated with their 
functional properties. Mainly, high SR/low threshold fibers have larger axon 
diameters compared to low SR/high threshold fibers, which have smaller 
diameters. Since axon diameter is related to thickness of myelination, high SR 
fibers may be more myelinated and low SR fibers may be less myelinated. Aside 
from the lengthening of the axonal nodes, we also show that the range of axonal 
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node lengths from min to max is much more variable in P21/1M compared to P14. 
This finding may indicate the presence of the different subtypes, with high SR 
axonal nodes possibly on the shorter end, and low SR axonal nodes possibly on 
the longer end of the length spectrum. To further study this idea, we would have 
to measure the nodes from the different subtypes to determine if each subtype is 
associated with a certain axonal node length. 
In this chapter, we also showed the differing myelin morphologies of the 
SGC compared to the SC. We found that SGC myelination of the SGN cell body, 
although multi-layered, is less dense and especially less compact, as we show 
through our ultrastructural studies of SGC paranodes. SGC myelination is slower 
than SC myelination, since terminal myelin loop heads are fewer and are not 
strongly connected to the axolemma in P14 SGC paranodes. By 1M, even though 
there are more SGC terminal myelin loop heads that are strongly connected to the 
axolemma, the glial-glial connections between the loop heads are not as tight when 
compared to the connection between SC loop heads at either P14 or 1M. We show 
that ganglion nodes lengths decrease between hearing onset (P14) and hearing 
maturation (P21). The decreasing lengths between P14 and P21 may be due to 
the continuing SGC myelination. Not much is known about the function of SGCs, 
especially in the AN, but they are thought to play a role in supporting neuronal 
metabolism due to the presence of amino acid, nucleobase, and fatty-acid 
transporters on their surfaces110. SGCs myelinating cell bodies of other nerves are 
more commonly reviewed in the aspect of neuropathic pain111,112. In the trigeminal 
nerve, the inhibition of Kir4.1 expression on the SGCs are shown to cause 
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dysfunction in potassium buffering, which leads to pain-like behavior in the mutant 
mice113. A recent study of the SGCs myelinating the dorsal root ganglia show that 
fractalkines resulting from induced inflammation target SGCs, which then produce 
inflammatory factors that are associated with hypernociception114. In the AN, we 
are able to show that SGC myelin/paranode morphology is different compared to 
SC myelin/paranode, but we are not absolutely certain of the functional 
significance of that differing morphology. At present, there are no studies querying 
pain associated with SGCs in the AN. We do show that a change in ganglion node 
length, but not axonal node length, is associated with amplitude growth. Perhaps 
in the AN, myelination of the SGN by SGCs is necessary for ease of depolarization 
of the large cell body.  
Previous studies have shown that mice showing nodal abnormalities also 
have decreased hearing sensitivity. High intensity noise-injury was shown to lead 
to disruption of the axonal paranodes51 and transient ablation of glial cells was 
shown to lead to disruption of heminodal clustering14. The link between 
formation/maturation of normal nodal structures, especially that of the ganglion 
nodes, and proper AN function had yet to be studied. Here we showed that 
maturation of nodal structures after hearing onset (i.e., shortening of ganglion 
nodes, and elongation of axonal nodes), are associated with decreasing AN firing 
latencies. We also show that decreasing ganglion node lengths are correlated with 
increasing amplitude slopes. Our studies with the Dmdo/Dmdo mice also support 
the findings that proper heminodal clustering is important for normal AN function. 
With these findings, we determined that normal nodal formation/maturation 
Page 83 
 








































†Chapter 4: Glial dysfunction after noise injury leads to dysmyelination and 
loss of hearing function 
 
 
†The following chapter includes data modified from an article we published in the 
Journal of Neuroscience on March 7, 2018.  
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4.1 Introduction  
 
 After characterizing the different nodal types in the AN and highlighting the 
importance of proper myelination and nodal development/maturation in 
association with AN functional maturation, we wanted to next elucidate the 
relationship between noise injury and myelination. Studying myelin and the 
affiliated nodal structure maintenance, especially at the paranodal domain, as 
well as glial-related molecules, can be used to interpret glial cell function.   
Hearing loss due to noise-injury has been a long-studied topic, with 
permanent threshold shifts (PTS) being apparent with high intensity noise 
exposure (≥106 dB). Studies by Liberman and Kujawa show that lower intensity 
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noise exposure may result in temporary threshold shifts but with loss of synaptic 
connection between the IHCs and AN afferent fibers causing suprathreshold 
response deficits13. Aside from synapse loss, many researchers attribute the 
cause of noise-induced hearing loss to death of hair cells115–117, degeneration of 
lateral wall118,119, and loss of AN neurons120–122. One component of the cochlea, 
the auditory glial cells, have not been so well-studied in the post-noise setting.  
About 95% of AN fibers are myelinated by cochlear glia, i.e., the SCs 
enwrapping the axonal processes and the SGCs shrouding individual somata. 
Myelinating glia regulate assembly of cellular adhesion molecules and ion 
channels that are key elements of axo-glial junctions and the paranodal 
structures at the node of Ranvier, a critical structure for saltatory conduction123.  
Cochlear glia-associated paranodal structures and nodal clusters of Na+ channels 
are present along the entire length of AN processes where there are gaps 
between myelin50,124. In the brain, dynamic regulation of nerve myelination, 
required for nerve plasticity and repair, continues into adulthood125,126. Myelin 
deficiencies can significantly deplete neuronal activity due to loss of conduction 
velocity. 
RNA binding proteins (RBPs) control post-transcriptional events such as 
pre-mRNA splicing and mRNA stability, localization and translation127. This wide 
range of function allows these proteins to modulate the proteome of neural 
progenitor cells needed to facilitate differentiation into glial and neuronal cells 
and to conduct myelination and form neural circuitry57. RBPs are known to have 
numerous downstream targets, and manipulation or dysregulation of these RBPs 
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can have extensive effects. The Quaking (qkI) gene encodes a KH-type family of 
RBPs and generates three major spliced transcripts encoding QKI-5, QKI-6, and 
QKI-7 isoforms that differ in their C-termini 53,128.  QKI-5 harbors a nuclear 
localization signal and is located in the nucleus, while QKI-6 is expressed 
throughout the cell and QKI-7 is cytoplasmic 57,129.  QKI-5 and QKI-6 directly or 
indirectly regulate myelin-specific genes such as myelin-associated 
glycoprotein130–132. QKI-6 and -7 are largely expressed during active 
myelination128. In the quaking viable mouse model, which is known for its myelin 
deficiency, the qkI isoforms and corresponding RBPs were reduced in glial cells 
compared to their wildtype counterparts128,133.  
In this study, we have examined the linkage between noise exposure and 
demyelination of SGNs and peripheral processes, focusing on the molecular 
mechanisms that drive myelinating glial dysfunction. For this purpose, we 
employed a noise-exposure paradigm in mice that resulted in permanent 
hearing loss. Our data show that noise exposure causes demyelination of 
SGNs and disruption of paranodal axo-glial junctions, promoting 
demyelination-associated inflammatory responses and widespread changes in 
myelin-related gene expression in the AN. Noise exposure caused a rapid 
response in QKI-RBP expression that was accompanied by changes in the 
expression of numerous QKI targets associated with myelination. Similar 
investigation of postnatal AN development revealed that upregulation of qkI-6 
and qkI-7 and downregulation of qkI-5 occurred around the first two weeks after 
birth, coinciding with myelination. Targeted deficiency of qkI/QKI-RBPs in adult 
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cochlear glia disrupted myelin structure and paranodal axo-glial junctions and 
resulted in hearing loss. Together, these results identify qkI/QKI-RBPs 
dysregulation as a critical early component in the noise response, leading to glia 
dysfunction, demyelination and hearing loss.   
 
 




4.2.1 Animals used  
 
Young-adult CBA/CaJ mice aged 6-15 weeks and mice at ages P0, 3, 7, 10, 14, 
and 21 were used for this project. The QKIFL/FL;PLPCreERT 59 model was produced 
by crossing QKIFL/FL, which has loxP sites flanking exon 2 of Quaking, with PLP-
CreERT72.  The knockout was induced in ~10-week-old QKIFL/FL;PLPCreERT mice by 
5 intraperitoneal injections of 10 mg/ml TAM at 1mg/25g once per day. The 
knockout of exon 2, which is common for the three major QKI isoforms QKI-5, -6, 
and -7, should result in a null allele59. Experiments were performed on ~15-week-
old QKIFL/FL;PLPCreERT  mice 28 days after the final TAM injection. Age-matched 
QKIFL/FL;- littermates were used as controls.  
 
 
4.2.2  Noise exposure 
Noise exposure procedures were modified from previous studies134.  
Young-adult CBA/CaJ mice were exposed to 8-16kHz octave-band noise at 
either 100dB, 106dB, or 112dB SPL for 2 hours using a Beyer DT48 drive 
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(Beyerdynamic, Farmingdale, NY) and monitored with a probe-tube microphone 
(B&K 4134; Bruel and Kjaer, Norcross, GA).   
 
4.2.3 Physiological procedures 
Mice anesthetized with ketamine/xylazine cocktail were tested for their 
ABR responses. ABR testing on the CBA/CaJ mice in this study was performed 
in in a sound-isolation booth at MUSC. For the young-adult CBA/CaJ mice, ABRs 
were measured at 4, 5.6, 11.3, 16, 22.6, 32, 40, and 45.2 kHz frequencies. 
Stimuli were delivered 31 times/s and the signal consisted of 5ms tone pips with 
cos2 rise/fall times of 0.5ms. Responses were recorded from sound intensity 
levels from 90-10dB and each succeeding level was reduced by 5 dB steps. 
Wave I thresholds and suprathreshold responses of onset latency and peak 
amplitude were analyzed for each tested frequency. Pre-noise ABR recordings 
were used for as the control comparison, as well as for non-noise-exposed mice 
whose cochlea were used as control samples. For mice given noise exposure, 
ABRs were recorded immediately (Im), Day (D)1, D3, D7, D14, and/or D30 after 
noise exposure. ANs were harvested after each experimental time point. For 
each noise and control group, thresholds were averaged at each frequency and 
mean ± standard error of mean (SEM) were calculated and plotted using Origin 
6.0 software (OriginLab Corporation, Northampton, MA).  For suprathreshold 
amplitude and onset latency, measurements for no-noise control and day 3 post-
noise groups were averaged at each intensity level for each frequency.   
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ABR measurements were performed and collected from the right ears of 
each for mutant QKIFL/FL;PLPCreERT and QKIFL/FL;- littermate control mouse using a 
portable SmartEP system and software (Version 3.97) (Intelligent Hearing 
Systems, Miami, FL). Testing on these mice were performed in a portable sound-
isolation apparatus at the Lady Davis Institute for Medical Research.  ABRs were 
recorded just before the mice were sacrificed and ANs were collected. The ABRs 
were evoked at 8 and 16 kHz frequencies. The stimuli consisted of 1ms in length 
Blackman pure tones which were delivered at 19.3 times/s.  Sound intensity 
levels from 100-10dB SPL were tested, with each succeeding step being reduced 
by 10dB.  Wave I thresholds were plotted by mean ± SEM for each frequency for 
each mouse group. Suprathreshold wave I peak amplitudes and peak latencies 
were plotted by mean ± SEM for each sound intensity level/frequency.  
 
4.2.4 Microarray analyses  
Noise-exposed AN samples were collected at Im, D1, D7, and D14 after 
exposure. Comparative analyses were conducted with dChip software.  AN 
samples were collected from mice of both sexes (n = 9 females, 6 males). To 
eliminate sex as a confounding variable, genes that were determined to be sex-
dependent were excluded from all following microarray analyses. For unbiased 
expression analysis of the effect of noise, significant difference was defined as 
absolute fold change >1.5 and p <0.05 (Student’s t-test, unpaired, 2-tailed) for at 
least one pairwise relationship among the control and post-noise time points; 
FDR, estimated based on iterative comparisons using permuted group 
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assignments, approximated 24%.  Enrichment analysis of biological process 
terms was conducted with DAVID (Database for Annotation, Visualization, and 
Integrated Discovery) 135,136. Significantly enriched biological processes (adjusted 
p <0.05, Benjamini and Hochberg adjustment) were summarized with REVIGO 
137.  A set of myelin-related genes was compiled from several resources: 1) 
mRNAs enriched in myelinating oligodendrocytes in mouse cerebral cortex 
compared to astrocytes, neurons, oligodendrocyte progenitor cells, newly formed 
oligodendrocytes, microglia, and endothelia at FPKM thresholds of 0.1, 1, 10, 20 
138; 2) mRNAs with normalized read counts of >100 and >2-fold increase in male 
mouse brain myelin 139; 3) genes on the mouse 430 2.0 GeneChip (Affymetrix) 
identified by query for the term myelin; and 4) a curated set of genes related to 
the node of Ranvier.  A set of putative QKI target genes was compiled from 
genes alternatively spliced in a model of QKI deficiency 59 and genes containing 
a QKI response element (QRE) 140.  Gene sets were processed with the NetAffx 
webtool (Affymetrix) to match genes with corresponding microarray content.  
Differential expression for focused analysis of myelin-related and putative QKI 
target gene sets was defined as p <0.05 (Student’s t-test, unpaired, 2-tailed) for 





Reverse transcription of total RNA was performed with the iScript cDNA 
synthesis kit (Bio-Rad) according to manufacturer protocol. Amounts of 25-50 ng 
of total RNA were used in 20 µl reaction volumes and the obtained cDNA 
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products were diluted to 100 µl with nuclease-free water.  qPCR was conducted 
as previously described141 in a CFX96 instrument (Bio-Rad) using SsoAdvanced 
Universal SYBR Green Supermix (Bio-Rad).  Quantification of relative expression 
of our genes of interest were completed using the PCR Miner Web tool80.  
Relative mRNA expression values for experimental genes were normalized using 
the reference genes Tbp, Hprt and Actb. 
 
 
4.2.6 G ratio measurements   
 
Myelin ultrastructures of mutant QKIFL/FL;PLPCreERT and control QKIFL/FL;- 
cochleas were analyzed via TEM.  The myelin thickness and axonal diameters 
were measured from 3 ANs per experimental group, with 187 fibers being 
measured from the mutants and 224 fibers being measured from the controls. G 
ratios were calculated using the open-source imaging software, Fiji 142, with the G 


























4.3.1 Noise-induced functional declines in the young-adult CBA/CaJ mouse 
AN 
 
We first characterized pathophysiological alterations in cochleae of adult 
CBA/CaJ mice exposed to octave-band noise (8-16 kHz) at 106dB SPL for 2 
hours. ABRs were measured at several time points after noise exposure to 
evaluate AN function. We calculated and show the threshold shifts, which can be 
found by subtracting the pre-noise threshold from the post-noise threshold 
results. For noise exposure at SPLs of 106dB, threshold shifts up to ~65 dB were 
seen at Im (Figure 4.3.1 a). Although wave I thresholds improved by D3, PTS of 
>20 dB were present at 16 kHz and higher frequency regions for the 106 dB 
exposure. Suprathreshold measurements of amplitudes (Figure 4.3.1 b) showed 
significantly reduced wave I amplitudes D3 after noise compared to control. 
These results apparent for the mid-frequency at 11.3 kHz and much more so for 
the higher frequency at 32.kHz. To determine possible delays in conduction after 
D3 noise, we also measured onset latencies of wave I (Figure 4.3.1 c). We 
found that, especially in the higher frequency, there were significant delays in 
wave I latency in D3 compared to non-noise exposed controls. Larger, 
permanent threshold shifts and diminished wave I amplitudes post-noise can be 
explained by noise-induced hair cell death, as well as SGN apoptosis. The longer 












Figure 4.3.1: Noise-induced functional declines in the young-adult CBA/CaJ 
mouse AN 
(a) ABR wave I threshold shifts showed dynamic alterations of mouse hearing 
sensitivity after noise exposure (b) Wave I amplitudes were reduced at 11.3 kHz 
(n = 11-17 noise; 16-17 control mice) and even more so at 32 kHz (n = 8-17 
noise; 17 control mice) at D3 after 106 dB noise exposure (c) Onset latencies of 
wave I did not greatly change at 11.3 kHz (n = 11 noise, 17 control), but were 
significantly longer at 32 kHz (n = 8-17 noise, 17 control). (*p < 0.05, **p < 0.01 
















4.3.2 Noise-induced demyelination, disruption of paranodal axo-glial 
junctions, and recruitment of macrophages   
 
Our previous studies of mouse and human cochleae demonstrated that 
myelin abnormalities occur prior to a significant AN loss, suggesting that glial 
dysfunction plays a critical role in the early phase of AN degeneration in 
sensorineural hearing loss81. To investigate this supposition, we examined 
ultrastructure of myelinating glia in mice exposed to 106 or 112 dB noise.   
Since this exposure paradigm induces PTS in the frequency range of 16 kHz and 
above (Figure 4.3.1 a), sections from 16-45.6 kHz regions of the cochlea were 
selected for TEM examination. Electron micrographs from control mice showed 
that type I SGNs are ensheathed with multiple layers of compact myelin lamellae 
proximal to the glia and multiple layers of non-compact myelin lamellae proximal 
to the neuron (Figure 4.3.2 a,b). Myelinating cells enclosing axons have often 
only compact myelin (Figure 4.3.2 b). Myelin paranodal loops were seen to be in 
tight contact with axons through axo-glial junctions (Figure 4.3.2 b).  
Loss/disruption of myelin was frequently observed in the AN nerve within RC at 
D1 (Figure 4.3.2 c), whereas no gross pathological alterations were seen in the 
neuronal bodies. Disruptions were also present in paranodal axo-glial junctions 
(Figure 4.3.2 d). Myelin abnormalities were more pronounced at D14 and 
included loss/disruption of compact myelin lamellae and the appearance of 












Figure 4.3.2: Noise-induced demyelination, disruption of paranodal axo-
glial junctions, and recruitment of macrophages    
(a, b) Normal type I (I) SGNs and myelinating glial cells in an adult CBA/CaJ 
mouse. Enlargements of (b) show compact myelin lamellae (white arrowheads) 
and paranodal axo-glial junctions (black arrowheads). (c) Disruption of the myelin 
sheath surrounding neurons (asterisk), (d) loosening of SGN myelin (white 
arrowhead), and disruption of axo-glial junctions (black arrowhead) D1 after 
106dB noise. (e) Myelin whorls and cytoplasmic vacuolization (arrows) of 
dysmyelinated SGNs D14 after 106 dB noise. (f) Reduction (arrows) and 
eventual loss (arrowheads) of NrCAM+ nodal structures at the habenula at D1 
after 112 dB noise. (g) No Iba-1+ macrophages seen in control AN. (h-i) 
Increased presence of Iba-1+ macrophages in OSL (h) and RC (i) are seen D1 



















Neuronal cell adhesion molecule (NrCAM) is expressed in the nodal 
axolemma and plays an important role in maintenance of the axon initial segment 
and the nodes of Ranvier 38. Immunostaining of the AN with anti-NrCAM antibody 
at D1 revealed a loss of axon initial segments (heminodal) at the habenula 
opening in regions encoding 8 kHz and higher frequencies (Figure 4.3.2 f).  
These results were consistent with the appearance of myelin abnormalities and 
disruption of paranodal structures at similar frequencies, perhaps leading to 
slower conduction velocities.   
 Macrophages contribute to the process of nerve degeneration by 
phagocytosing myelin debris and axonal remnants. Macrophage 
recruitment/migration into the cochlea has been reported to occur following 
noise-induced cochlear insult 143,144, ototoxic drug-induced SGN degeneration 145 
and genetic modification-induced hair cell loss 146. To validate the presence of 
macrophages in the AN, sections from control and noise-exposed ears were 
immunostained with Iba1, a key calcium binding protein that is expressed by 
microglia/macrophages, but not neural cells 147.  Iba1+ macrophages were 
present in several regions of the AN in noise-exposed cochleae compared to 
control (Figure 3.4.2 g-i). 
 
4.3.3 Expression patterns of QKI variants and potential targets of QKI in 
response to noise injury 
 
To understand molecular changes following noise exposure, we 
performed microarray transcriptional profiling on AN from control adult mice and 
mice at Im, D1, D7, or D14 (n = 3 per group).  Differential expression analysis 
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identified 1247 gene representations (probe sets) corresponding to 901 unique 
genes that were significantly different among the pairwise relationships (Figure 
4.3.3 a).  Examination of expression patterns for the noise responsive genes 
showed that most exhibited transient up- or down-regulation after exposure that 
peaked in Im or D1 samples, but returned to near normal levels in D14 samples. 
Analysis of biological processes enriched among all of the differentially 
expressed genes detected a core set of related processes associated with 
wounding and inflammation (Figure 4.3.3 b, upper network), including the 
process that had the overall highest enrichment score, immune response (padj = 
5.9 E-08). Also enriched among the differentially expressed genes was a set 
associated with apoptosis and DNA metabolism (Figure 4.3.3 b, middle network) 
and independent processes that included cell cycle and positive regulation of 
development (Figure 4.3.3 b, lower panel).  
To address the myelin pathologies observed following noise exposure, we 
specifically examined expression data for myelin-related genes. The list of myelin 
genes interrogated was compiled from several sources, including the gene 
ontology database and data sets produced from recent RNA-seq profiling of 
myelinating cells 138,139. The compiled myelin list comprised 1849 unique genes 
that in turn corresponded to 3510 probe sets for the microarray platform used in 
our experiments.  Analysis of expression of these myelin-related genes in 
response to noise (Figure 4.3.3 c) found that roughly half were statistically 
different (p <0.05) for at least one pairwise relationship in our data set (1063 of 




Figure 4.3.3 Expression patterns of QKI variants and potential targets of 
QKI in response to noise injury 
 
(a) Microarray analysis identified 1247 gene probe sets differentially expressed 
(fold change >1.5 and p<0.05; Student’s unpaired t-test) following noise. (b) 
Enrichment analysis results for gene ontology biological process terms 
associated with the analysis in a. (c) Microarray expression profiles of 1560 
myelin-related genes probe sets that were affected by noise exposure (p <0.05, 
Student’s unpaired t-test). (d) Relative expression levels of all QKI mRNA (Pan) 
and QKI variants in control mice and mice at D1 after noise exposure. (e)  
Overlap between myelin-related genes and putative QKI targets regulated by 
noise exposure. (f) (Left panel) Microarray expression profiles for the 143 gene 
probe sets depicted in that are myelin related, putative QKI targets and 
differentially expressed in response to noise. (Right panel) Expression profiles of 
the 143 genes in the developmental ANs at P0-21. (g) Average relative (Z 
standardization) expression patterns for clustered genes identified in f. Relative 
noise responses are summarized by line graph (blue); relative developmental 
patterns are summarized by area graph (yellow). 
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Clustering analysis of expression patterns for these genes again showed that 
many underwent transient up- or down-regulation that peaked in Im or D1 
samples.  
Among genes differentially expressed in response to noise, the qkI gene is 
well characterized as a key regulator for the formation and maintenance of 
myelin and axo-glial junctions in the central nervous system 59. The qkI gene 
generates three major spliced transcripts encoding QKI-5, QKI-6, and QKI-7 
isoforms 53.  Here we examined the expression of total QKI (pan) and specific 
variants in response to noise. Quantitative PCR analysis of isoform expression in 
the mouse AN 1 day after noise exposure revealed significant change in QKI-7 
but not in QKI-5 and -6 (Figure 4.3.3 d). These data, coupled with our findings of 
differential expression of QKI by microarray, demonstrated that QKI isoform 
expression is altered in response to noise and suggests that targets of QKI may 
also be affected. 
We therefore reanalyzed the microarray expression data to examine 
putative targets of QKI-RBPs, compiling a list of 1416 mRNAs containing the QKI 
response element (QRE), a bipartite consensus binding sequence 140, and 28 
RNAs detected as differentially spliced in mouse oligodendrocytes 59.  
Collectively, the list of putative QKI targets corresponded to 3102 probe sets on 
the microarray platform used for our study. Query of these probe sets revealed 
that 1297 (42%) were statistically different (p <0.05, Student’s t-test, unpaired) for 
at least one pairwise relationship in our data set. Clustering analysis of 
expression patterns for these putative QKI targets regulated by noise again 
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showed that most underwent transient up- or down-regulation peaking at Im or 
D1 after noise exposure.   
Given the established relationship between QKI and myelin148, we 
determined the overlap between the myelin-related genes affected by noise and 
the putative QKI targets affected by noise. Of the 1560 differentially expressed 
myelin related probe sets and the 1297 differentially expressed QKI target probe 
sets, 143 were both myelin-related and putative QKI targets (Figure 4.3.3 e) 
Unsurprisingly, QKI was one of the genes identified by this analysis; other genes 
of interest included Cdc42, Irgn1, Ugt8a, Egr2, Mal, Kcna1, NF1 and Nfasc.   
Our previous study revealed that acute nerve injury caused transcriptional effects 
in the AN resembling a developmental transition from mature to immature state 
74. For example, AN injury caused up-regulation of Sox2 and other neural 
progenitor-related genes and increased proliferation of a subset of glial cells.  
Specific temporal patterns of QKI expression in developing nerve tissue are 
associated with the states of glial cell differentiation and myelination. For 
example, expression of QKI-6 and QKI-7 peak around P14, coinciding with 
myelination of brain tissues 53,128. We next examined if this select group of genes, 
which are myelin-related, and putative QKI targets that are responsive to noise 
injury also exhibited evidence of developmental regulation. To address this, we 
queried our previously described microarray data set that profiled mouse auditory 
development from postnatal days 0 to 21 (P0-P21) 74, which covers a critical 
period for glial maturation and myelination.  Clustering analysis of these genes 
(Figure 4.3.3 f) revealed that nearly all showed vivid patterns of up- or 
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downregulation during the developmental period.  Inspection of the heatmap 
involving both injury and development profiles identified three prominent clusters, 
with two (clusters 1 and 2) showing up-regulation by noise and down-regulation 
during development and the third (cluster 3) showing the opposing pattern of 
downregulation by noise and upregulation during development (Figure 4.3.3 g).  
Among these clusters, only cluster 1 showed temporal patterns for development 
and noise-exposure that were fundamentally similar.  For clusters 2 and 3, the 
developmental and injury temporal response patterns were largely opposing.  Of 
the 143 myelin-related, putative QKI target, noise responsive genes, 98 were 
present in these three clusters (69%).  Opposing temporal relationships were 
also apparent in the unclustered QKI targets, which contain 31% of myelin-
related QKI targets.  These results highlight that there is similarity but also 
discordance in how putative QKI targets are regulated in the developmental, pro-
myelination state, versus the injury response state.   
 
4.3.4 Expression patterns of QKI isoforms in postnatal and adult ANs.   
To extend our observation of QKI regulation in AN during postnatal 
development, we analyzed expression of total QKI (Pan) and the three different 
isoforms, focusing on three critical stages of myelination: P3, 7, and 14 (Figure 
4.3.4 a) Pan-QKI expression increased gradually through postnatal development, 







Figure 4.3.4: Expression patterns of QKI variants in normal postnatal and 
adult AN 
(a) Expression levels of qkI-5 mRNA decrease from postnatal (P) day 3 to 14, 
while QKI-6 and QKI-7 levels increase from P3 to P14, presenting a pattern 
similar to that seen for Pan-QKI.  Relative expression levels of all QKI mRNA 
(Pan and QKI variants) were measured by qPCR analysis in the ANs of CBA/CaJ 
mice at P3, P7, and P14.  Expression levels shown are normalized to Hprt and 
Actb; error bars indicate SEM; * p <0.05, ** p <0.01, and * p <0.001 by ANOVA 
with Bonferroni’s post-test. N = 3 mice/time point. (b) Low magnification image of 
AN section immunostained with anti-Pan-QKI highlighting location of RC where 
all images were obtained. (c-g) Immunostaining with anti-QKI antibodies showing 
protein expression patterns of QKI-RBPs in the glial cells, but not neurons (white 
arrows) of the normal ANs from mice aged 2 months (2M; c,d,f) or 14 days (e) 
and temporal bone from a human ear, aged 38 years (g). The nuclei were 








All three of these transcripts were detectable throughout postnatal 
development with qki-7 being more abundant than qkI-5 and qkI-6. The isoforms 
qkI-6 and qki-7 were both significantly upregulated during postnatal development 
while qkI-5 was significantly downregulated. These patterns match findings for 
qkI isoform expression in the mouse brain53, with qkI-6 and qki-7 increasing and 
qkI-6 and qki-7 decreasing in the mouse AN at times that coincide with the onset 
of myelination.  
We further examined auditory QKI expression, detecting total and variant 
QKI proteins in mouse and human cochlear sections.  Analyses in mice were 
focused on RC (Figure 4.3.4 b), which contains SGCs that ensheath soma of 
SGNs and SCs that myelinate fibers.  Immunohistochemical analyses were done 
on cochlear sections from 2-month-old young-adult mice (Figure 4.3.4 c-f) and 
P14 mice (Figure 4.3.4 e), and both ears from a 38-year-old human donor 
(Figure 4.3.4 g). QKI-5 was expressed in nuclei of both SCs and SGCs (Figure 
4.3.4 c).  QKI-6 and -7 were expressed predominantly in the cytoplasm of glia 
surrounding SGNs and fibers (Figure 4.3.4 d,e).  Pan-QKI detection in mouse 
confirmed that total QKI protein was distributed in both nucleus and cytoplasm 
but that it was limited to glial cells (Figure 4.3.4 f). Pan-QKI detection in human 
temporal bones revealed a similar distribution, with QKI present in nuclei and 






4.3.5 Reduction of QKI protein expression in AN glial cells of adult 
QKIFL/FL;PLPCreERT mice 
 
To investigate the importance of QKI-RBPs to glial cell function in the 
auditory system, we examined the effects of qkI deficiency by using the 
QKIFL/FL;PLPCreERT mouse model that targets all qkI variants in glial cells.  The 
QKIFL/FL;PLPCreERT mouse model was generated by crossing QKIFL/FL with an 
inducible Cre knockout line, PLP-CreERT, that induces qkI knockout in Plp1 
expressing glial cells after being activated by injections of TAM72.   
 Immunostaining analyses of RC and OSL regions were performed on 
cochleae of 15-week-old TAM-treated QKIFL/FL;PLPCreERT mice and compared to 
QKIFL/FL;- littermate controls  (Figure 4.3.5 a).  Immunostaining for Pan-QKI 
showed that nuclear QKI was notably reduced in SGC nuclei in QKI deficient 
cochleae compared to glia in control cochlea (Figure 4.3.5 b).  QKI was also 
substantially reduced in glial cytoplasm of QKIFL/FL;PLPCreERT mice compared to 
controls, which had a QKI distribution comparable to that seen in CBA/CaJ mice 
(Figure 4.3.4 f).  Figure 4.3.5c illustrates a substantial loss of QKI in nuclei and 
cytoplasm of SCs ensheathing peripheral fibers in the OSL.  To determine QKI 
reduction specifically in the glial cells, dual immunostaining was performed for 















Figure 4.3.5: Reduction of QKI protein expression in AN glial cells of adult 
QKIFL/FL;PLPCreERT mice 
(a) Low magnification images of QKIFL/FL;- and QKIFL/FL;PLPCreERT ANs after TAM 
immunolabeled for Pan-QKI and Sox10.  RC, OSL, and Hab regions are 
indicated.  Nuclei were counter stained with PI. (b,c) Pan-QKI (QKI) 
immunoreactivity in glial cell nuclei is greatly reduced in both RC (b) and the OSL 
(c) of QKI exon 2 mutation mice.  Control QKIFL/FL;- and mutant QKIFL/FL;PLPCreERT  
mice were evaluated 4 weeks after TAM injections. (d) Dual immunolabeling for 
Pan-QKI and Sox10, demonstrates the loss of QKI expression in most Sox10+ 
glial cells (green).  Nuclei were counter stained with DAPI. (e-f) Cell density 
counts for total glial cells in OSL (as indicated by Sox10+ cells) and glial cells 
expressing QKI (as indicated by cells positive for both Sox10 and Pan-QKI) in 
OSL (e) and RC (f) from the three cochlear turns in QKIFL/FL;- and mutant 
QKIFL/FL;PLPCreERT mice. Total glial cells, based on density, were not significantly 
different between control and mutant mice in the OSL and RC of any of the turns 
(left panels for e,f).  There were almost no QKI positive glial cells in the OSL (e; 
right panel); QKI positive glial cell density in RC (f; right panel) was decreased by 
more than half in all cochlear turns in QKI deficient mice compared to controls. N 
= 4 for each group; error bars indicate SEM; * p <0.05 by the Mann-Whitney test 
(g-j) Dual immunostaining for Pan-QKI and Sox2, a glial progenitor marker, 
revealed much higher reactivity of Sox2 in the OSL (g-h) and RC (i-j) in 
QKIFL/FL;PLPCreERT compared to control QKIFL/FL;- mice. Scale bars: 50 µm in a and 















We chose the pro-differentiation/myelination factor Sox10 because it is 
expressed in fully differentiated, mature SCs in the adult peripheral nervous 
system149,151,152. In control mice, QKI colocalized with Sox10 in nuclei of SGCs 
and SCs in RC (Figure 4.3.5 d).  However, only few QK+ cells stained positively 
with Sox10 antibody in QKI-deficient mice (Figure 4.3.5 d).  Quantification of 
Sox10+ glia cells expressing QKI showed that there was a profound reduction in 
Pan-QKI+/Sox10+/DAPI+ cell density in the OSL of QKIFL/FL;PLPCreERT mice 
compared to controls (Figure 4.3.5 e). Quantification of Pan-QKI+/Sox10+/DAPI+ 
cells in RC also showed a significantly reduced density in QKI-deficient mice 
compared to controls (Figure 4.3.5 f). Total glia cell counts were not significantly 
different between QKIFL/FL;- and QKIFL/FL;PLPCreERT ANs.  
 To investigate further the consequences of QKI deficiency in cochlear glial 
cells, we evaluated distribution of Sox2, a glial progenitor marker153,154, in control 
and QKI-deficient mice. Sox2 is a marker of immature, undifferentiated glia and 
negatively regulates myelination by inhibiting SC differentiation153,155 and 
promotes a progenitor-like glial state associated with neuronal repair after 
injury156. Sox2 expression declines as glia mature155, but is present in SGCs in 
adult nerves157. In our studies, OSL of control mice contained only few Sox2+ 
cells and there was no colocalization of Sox2 with QKI in SCs (Figure 4.3.5 g).  
Sox2+ cells were more abundant in RC of control mice and these Sox2+ SGCs 
stained positively for Pan-QKI antibody (Figure 4.3.5 i). Interestingly, QKI-
deficient mice showed a substantially different profile of Sox2 expression. In the 
OSL, there was a notable increase in the number of Sox2+ SCs (Figure 4.3.5 h) 
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though there was still no evident colocalization of Sox2 and residual QKI in the 
mutant animals. In RC of QKI-deficient mice, Sox2+ SGCs appeared to be 
increased compared to controls (Figure 4.3.5 j). These findings suggest that QKI 
deficiency may lead to dedifferentiation in a subset of cochlear glia.  
 
 
4.3.6. Diminished QKI expression results in demyelination and disruption of 
paranodal structures in the adult AN 
 
To examine further the role of QKI-RBPs in AN architecture and function, 
we assessed ultrastructure of myelin and flanking paranodes in QKIFL/FL;PLPCreERT 
mice in OSL, Hab, and RC regions (Figure 4.3.6 e). We examined 41 nodal 
structures associated with 54 glial cells of 3 QKIFL/FL;PLPCreERT  mice, and 17 nodal 
structures associated with 34 glial cells of 3 QKIFL/FL;-  control mice. QKI-deficient 
mice showed evidence of hypomyelination, with a reduced number of lamellae 
wrapping some type I AN fibers (Figure 4.3.6 a,f). Mutants also exhibited 
aberrant myelin structure and the presence of unmyelinated fibers (Figure 4.3.6 
f). In addition, QKI-deficient mice exhibited pathologies in the paranodal region 
flanking the node of Ranvier.  In the control mice, terminal myelin loops of each 
lamellae were well-organized, closely-apposed to each other and appeared to 
have proper septate-like junctions connecting the loop heads to the axolemma 
(Figure 4.3.6 b). In the QKI-deficient animals, the paranode had thinner terminal 
loop heads that were more broadly spaced, with some large gaps present within 




























Figure 4.3.6: Diminished QKI expression results in demyelination and 
disruption of paranodal structures in the adult AN  
 
(a-d) Ultrastructural features of (a) AN fibers, (b) a paranodal junction, (c) axon 
initial segments at the habenula (Hab) opening and (d) SGNs in cochleae from 
control QKIFL/FL;- mice 4 weeks after TAM injections. (e) Low magnification image 
of a control AN highlighting the location of RC, OSL and Hab. (f-j) Abnormalities 
in myelin morphology around axons and type I (I) SGNs and paranodal structures 
in QKIFL/FL;PLPCreERT mice 4 weeks after TAM injections. Pathological 
manifestations associated with diminished QKI expression included missing 
nerve fibers (f; *), myelin enfolding (f; white arrows), thinning myelin or reduced 
myelin lamellae (f,i,j; black arrows), a loss of the myelin sheath at the axon initial 
segment (h; *), and cytoplasmic vacuolization in glial cells (i, black arrowheads).  
The image in g shows disruptions in a paranode (black arrowheads) of a mutant 
mouse.  Terminal myelin loops of the paranodal junctions flanking the nodes of 
Ranvier in the mutant mouse are disorganized, with abnormal spaces between 
the lamellae, and loop heads disconnected from the axolemma. Myelin lamellae 
ensheathing the somata of a mutant mouse are less compact and decreased in 
number (j; black arrow). (k) G ratio analysis revealed hypomyelination in the AN 
fibers, in particular the large-caliber fibers (with diameters >3 µm), in 
QKIFL/FL;PLPCreERT mice. N = 3 mice/group. (l-m) Immunostaining for paranodal 
Cntn1 and the neuronal marker neurofilament 200 showed that while numbers of 
NF+ nerve fibers (white arrows in m) remained similar, expression of paranodal 
Cntn1 was decreased greatly (white arrows in I, m) in mutant mice. (n-p) 
Immunostaining for Cntn1 and the nodal marker NrCAM revealed the 
disappearance of Cntn1+ paranodal flanks in heminodes at the Hab (white arrows 
in n), the nodes of Ranvier along fibers in the axonal (o) and in ganglion nodes 
(p).  ABR measurements from control and mutant mice showed no significant 
difference in ABR wave I thresholds (q) or amplitudes (r) between the two groups 
at 8 and 16 kHz.  In contrast, ABR wave I onset latencies (s) were significantly 
increased in the mutant mice (*p <0.05 by Student’s unpaired t test, n = 4 
QKIFL/FL;- mice; 3-4 QKIFL/FL;PLPCreERT mice). All data were presented as mean ± 
SEM.  Scale bars, 2 µm in a,f; 400 nm in b,g; 2 µm in c,d,h,i; 800 nm in j; 8 µm 











In the habenular region, where AN fibers form heminodes, demyelinate naturally 
and connect to the organ of Corti, the control AN showed thickly myelinated 
fibers close to the bony perforation, along with unmyelinated heminodes (Figure. 
4.3.6 c). In contrast, in the QKI-deficient sample there were few myelinated fibers 
which were in different states of dysmyelination, and there was a large open 
space clear of heminodes and axons (Figure 4.3.6 h). Soma of type I SGNs 
were densely myelinated and appeared healthy in control mice (Figure 4.3.6 d), 
whereas type I neurons in the QKI-deficient mice showed dysmyelination, with 
debris-laden spaces separating the cell membrane from the lamellae (Figure 
4.3.6 i). Additionally, regions of hypomyelination with limited, noncompact 
lamellae could be seen in close proximity to densely myelinated somata (Figure 
4.3.6 j). The observation of hypomyelination in the QKI-deficient animals was 
supported by a measured increase in the G ratio compared to controls (Figure 
4.3.6 k).  
 To understand what may be causing the structural aberration in the axo-
glial junctions at the paranodes in QKI-deficient animals, we performed co-
immunostaining for Cntn1, an axo-glial connector protein42, and neurofilament 
200158.  Sections from the OSL and RC in control samples showed characteristic 
paranodal patterns throughout the nerve fibers (Figure 4.3.6 l,m, upper panels).  
Conversely, Cntn1 staining and the distinctive patterns were largely absent in the 
QKI deficient samples (Figure 4.3.6 l,m; lower panels). As another measure of 
the effect of QKI deficiency on nodal structures, we performed dual 
immunostaining for NrCAM and Cntn1.  In QKI-deficient animals, paranodes 
Page 113 
 
flanking the heminodes were devoid of Cntn1 at the habenula (Figure 4.3.6 n; 
lower panel) and were mostly absent on the flanks of axonal nodes of Ranvier in 
the OSL compared to controls (Figure 4.3.6 o). Some Cntn1+ paranodal 
structures were seen in the RC in QKI-deficient cochleae (Figure 4.3.6 p).  
 AN function was tested in QKI-deficient animals by ABR measurements.  
Comparison of controls versus QKI-deficient animals showed that latencies of 
ABR wave I responses were significantly delayed for 8 and 16 kHz stimuli in QKI 
deficient animals (Figure 4.3.6 s). However, ABR thresholds of wave I were not 
significantly different between control and QKI-deficient groups for 8 and 16 kHz 
stimuli (Figure 4.3.6 q) and neither were the measured amplitudes (Figure 4.3.6 
r).  These findings show that QKI-deficient mice have ABR defects consistent 




4.4 Discussion  
 
While it is well-established that myelination of nerve fibers by myelinating 
glia, and dynamic regulation of this activity, is crucial for proper nerve function, 
little is known about pathological changes in cochlear myelinating glia following 
injury/stress such as noise exposure. Our findings show that noise exposure 
sufficient for inducing nerve degeneration and permanent hearing loss elicits a 
rapid cellular and molecular response on myelinating glia. Our data reveal that 
dysfunction of QKI-RBPs and their putative targets lead to myelinating glial 
dysfunction, resulting in SGN demyelination, disruption of paranodal axo-glial 
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junctions, and AN functional deficiencies. These findings implicate a new 
mechanism of AN functional deficiency in noise-induced hearing loss (NIHL).      
 In these studies, we used a model of NIHL with more severe noise 
exposure levels of 106 or 112 dB SPL for 2 hours at 8-16 kHz. Within a short 
time, young-adult mice showed PTS across most cochlear frequency regions. 
This exposure protocol generates a cochlear injury of sufficient magnitude to 
allow characterization of the cellular and molecular responses of the AN. In a 
previous study, a noise-exposure regimen of 110 dB SPL for 9 h in adult rat ears 
resulted in demyelination of the central portion of the AN and decreased 
conduction velocity51.  Our data expand on this important finding, showing that 
such noise causes demyelination of the SGNs and paranodal axo-glial junctions 
in the peripheral process in the ANs. These results are also consistent with a 
previous report in which thinner myelin sheaths were identified in the peripheral 
process of the AN after noise exposure159.   
 Another interesting finding of our study is that inflammatory cells, 
particularly activated macrophages, are involved in demyelination of SGNs and 
ANs after noise exposure. Our data showed that the macrophages appear to be 
recruited in regions of noise-induced demyelination. This was supported by our 
gene expression analysis, which found inflammation to be one of the top 
biological processes induced in AN after noise exposure. After injury in the 
peripheral nervous system, degenerating myelin and axon debris is 
phagocytosed by either resident or infiltrating macrophages160.  Emerging 
evidence suggests that macrophages can be both detrimental and beneficial with 
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regard to nerve regeneration and remyelination161. Our recent study 
demonstrated that hematopoietic-derived macrophages contribute to AN 
remodeling after SGN loss145.  Additionally, Kaur et al. (2015), reported that 
macrophage recruitment into the cochlea enhances survival of SGNs in a model 
of selective hair cell deletion. Further experiments are needed to determine 
whether macrophages in the AN promote remyelination of AN and neuron 
survival.   
 Glial proliferation following injury is an important aspect of remyelination 
involved in nerve repair.  In the peripheral nervous system, rapid SC proliferation 
is required for remyelination following injury162.  In the central nervous system, 
glia (e.g. oligodendrocytes) can proliferate after injury, but the period is more 
restricted than that of the SCs in the peripheral nervous system162.  Even under 
severe injury conditions that induce rapid type I SGN loss, glial cells show a 
dramatic increase in proliferation. However, despite this remarkable capacity of 
glial cells to proliferate in response to injury, there is no direct evidence of AN 
remyelination or axon regeneration after cochlear injury for animal models of 
NIHL, despite several decades of study163–168.  Here, our finding that QKI-RBPs 
and associated myelin targets undergo dysregulation after noise exposure 
provides molecular insight into the failure of remyelination and regeneration after 
noise injury and is potentially applicable to forms of neurodegenerative 
disease169.   
Here, our transcriptomic data revealed distinct QKI isoform expression 
patterns in noise-exposed animals as well as during mouse hearing 
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development.  During development, the transition from immature to mature 
(myelinating) state was matched by an increase in qkI-6 and qkI-7 and decrease 
in qkI-5.  Interestingly, in noise-exposed ANs, while there were suggestive 
expression differences for all qkI isoforms, only an up-regulation of qkI-7 was 
detected as significant. Thus, the qkI isoform expression pattern following noise 
injury does not fully recapitulate a developmental, pro-myelination state. These 
data suggest the possibility that this deficiency in the qkI isoform response, and 
the downstream consequences on myelin target gene expression, are causal 
factors in the failure of remyelination leading to NIHL. A better understanding of 
how qkI isoform expression is controlled in cochlear glia may lead to new 
therapeutic interventions for NIHL and other neurodegenerative disorders.       
Our studies reveal the critical roles of myelinating glia and QKI-RBPs in 
the maintenance of young-adult AN.  In response to noise injury, young-adult 
mice rapidly exhibit glial dysfunction and altered expression of QKI-RBPs in 
the AN. Transcriptomic analysis and pathophysiological evaluation of noise-
exposed mice indicate that these dysfunctions represent a primary response 
to noise injury that ultimately culminates in NIHL. Furthermore, our data 
suggests that the influence of qkI on myelination is dependent on precise 









Chapter 5: Glial dysfunction in auditory nerve development leads to 








In Chapter 3 we highlighted the importance of proper nodal formation and 
maturation for AN function. In addition to our findings, we found the methods we 
used in these nodal studies to be useful tools in assessing glial function, 
especially pertaining to their ability to generate and maintain normal compact 
myelin with strong, organized connections with SGN axolemma. In Chapter 4, we 
showed that AN glial cells become dysfunctional after noise injury, in part due to 
the dysregulation of QKI-RBPs and their downstream targets. We also 
determined that qkI KO in young-adults causes dysmyelination, leading to 
disruptions in the axo-glial connections at the paranodal domain and loss of 
hearing function. Thus far, we showed the importance of normal myelination and 
nodal formation/maturation for enhancement of hearing function after hearing 
onset and revealed the importance of myelin/axo-glial maintenance for normal 
hearing function after noise injury.  
In both the developmental and noise settings that we studied, there are 
other cochlear factors that are involved that are affecting hearing function. During 
cochlear development, there are other cochlear components forming and 
maturing. The stria vascularis of the cochlear lateral wall is composed of cells 
that are responsible for potassium cycling in the endolymph. Potassium in the 
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endolymph and the generation of the endocochlear potential is required for 
proper mechanotransduction of the IHCs. Both the emergence of the 
endocochlear potential and the maturation of HCs, especially the connection 
between HC synapse ribbons and the afferent AN fibers, occur during early 
postnatal development around the onset of hearing103,170. In noise injury, the HCs 
and lateral wall are affected along with the AN fibers/glia. We and other 
studies118 show that hair cells degenerate after high-intensity noise exposure that 
resulting in PTS. Lower-intensity noise exposures also cause synapse ribbon 
loss that result in temporary threshold shifts13. After noise, the cochlear lateral 
wall show signs of edema and the endocochlear potential is reduced118,119, both 
of which are associated with NIHL.  
From our studies in Chapter 4, we found that knocking out qkI in young-
adult mice caused glial dysfunction which led to dysmyelination and reduced 
hearing function, mainly through slowing of AN conduction velocity. We showed 
that in the young-adult AN, qkI and the QKI RBPs it encodes are important for 
maintaining myelination of the type I SGNs. However, the role of qkI during AN 
development is not as clear. The purpose for the studies in this chapter is two 
parts. First, we wanted to determine the effects of primary glial dysfunction via 
induced qkI KO on AN structural and functional development and maturation. 
Second, we wanted to elucidate the role of qkI around the critical period of AN 
myelination by determining the effects of its depletion on formation of myelin, 
nodal assembly, and auditory functional development/maturation by knocking it 
out pre-peak myelination and during peak myelination. Our findings in this 
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chapter would demonstrate the importance of normally functioning glial cells for 
proper AN function and elevate the AN glial cells and qkI as valid therapeutic 
targets in SNHL.  
 
  




5.2.1 Animals used  
 
CBA/CaJ mice aged P3 and P7 were used for AN harvesting and 
subsequent RNA-seq from total AN RNA. These data sets were the same as the 
ones used in Chapter 3. We also compared myelin and axonal ultrastructure 
acquired from TEM of P3 and P7 CBA/CaJ mice. To analyze the effects of QKI 
depletion in auditory glial cells, QKIFL/FL;PLPCreERT (QKI-KO) pups were used with 
Cre-negative littermate controls (QKI-Ctrl). The TAM-induced knockout of qkI 
were generated via intraperitoneal injections of 10mg/ml TAM for 2-3 consecutive 
days starting at either P5 or P7. P5 was chosen to elucidate the effects of QKI-
KO pre-peak myelination (Group 1) and P7 was chosen to elucidate the effects of 
QKI-KO during peak myelination (Group 2). We chose P5 to represent the pre-
peak myelination time point instead of P3 because the survivability of the pups 
injected at P3, no matter the genotype, was less compared to P5. Due their 
larger size, P5 mice were more accurately injected with the correct amount of 
TAM and had less, if any, back flow of TAM solution from the injection site. After 
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induction, we measured ABR and collected ANs at two endpoints: P14 which is 
around the onset of hearing and P20/21 which, based on our studies in Chapter 
3, is around the period when the AN is functionally mature. See Figure 5.3.2 A 




5.2.2 RNA-seq analyses of expression of glia-related genes and putative 
QKI target genes in development  
 
The list of putative QKI-RBP target genes59,140 used in Chapter 4 were 
modified to be compatible with RNA-seq data sets and are used in these studies. 
In order to find genes possibly affected by qkI KO at either pre-peak or peak 
myelination, we compared differential expression of putative QKI-RBP target 
genes in P3 compared to P7 RNA-seq datasets (P>0.05, Student’s t-test, 
unpaired, two-tailed). The FDR for this analysis after 1000 permutations was 
1.7%. To narrow our list of DE genes for each time point, we sorted the genes by 
greatest absolute fold change (fc) per time point. We then looked at the top 15 
up-regulated genes for each period and performed enrichment analysis via 
DAVID on the combined list to find the top biological processes associated with 














5.3.1 Transcriptomic analyses of putative QKI targets pre-peak and during 
peak myelination 
 
Based on literature56,57,59,128 and our own studies in Chapter 4 showing 
qkI’s presence in the AN, specifically in the auditory glial cells (Figure 4.3.4) and 
their importance for myelin maintenance, we decided to use the inducible qkI KO 
mouse, QKIFL/FL;PLPCreERT,  as our model for developmental dysmyelination in the 
AN. Our next task was to determine which day(s) may be best for inducing the 
KO. Our RT-qPCR analysis in Figure 4.3.4 a shows that the qkI isoforms were 
all present in P3 and P7. It is of interest to us that qkI-7 is significantly 
differentially expressed between P3 and P7 ANs. Along with qkI-6, the qki-7 
isoform which encodes the QKI-7 RBP is important for promoting SC 
myelination58. It is also the isoform we have shown to be significantly differentially 
expressed after one day post-noise injury (Figure 4.3.3) and may be associated 
with the dysregulated expression of the QRE-containing targets after noise. 
Previous studies171 and our own findings (Figure 3.3.1 A, Figure 5.3.1 A,B) 
show that the onset of myelination in mouse AN occurs at around P3 and that 
peak myelination activity occurs at around P7. In Chapter 3, we showed that 
genes that were important components of myelin, which are also markers of 
mature, myelinating SCs27,94,95, and those that were associated with myelin 






Figure 5.3.1: Differences in the state of myelination and expression of 
putative QKI-RBP target genes in ANs between pre-peak and peak 
myelination   
This part of the study uses data acquired from postnatal CBA/CaJ mouse mouse 
ANs. A shows a representative image of P3 AN fibers, which are currently 
undergoing the beginnings of myelination. White arrowheads point to axons 
enwrapped by one layer of cytoplasm-dense SC processes which represent the 
myelination state of the majority of the AN fibers. The white arrow points to one 
of the few axons ensheathed by compact, multi-layered myelin. B shows a 
representative image of P7 AN fibers during the peak myelination stage. The 
majority of the fibers are densely myelinated. A representative myelinated fiber is 
marked by a white arrow. The black arrow indicates forming axo-glial 
connections in the paranodal domain. C is a schematic showing that 677 of the 
1388 putative QKI-RBP target genes were DE between P3 and P7. 323 of the 
targets were up-regulated in P3 and 354 of the targets were up-regulated in P7. 
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Here, we show a representative TEM image of the CBA/CaJ mouse AN fibers at 
P3, the majority of which are only surrounded by one layer of cytoplasm-filled SC 
process and one fiber of only few with compact, multi-lamellae myelin sheaths 
(Figure 5.3.1 A). At P7, most of the AN fibers are ensheathed by dense, 
compact myelin (Figure 5.3.1 B). The axo-glial connections between the terminal 
myelin loop layers and axolemma of the paranodal domains are being formed.  
In order to have a better molecular understanding of knocking out QKI 
around the critical myelination time point in early postnatal development, we 
queried the expression of putative QKI target genes containing QREs in our 
CBA/CaJ postnatal RNA-seq datasets (Figure 5.3.1 C). We compared the two 
time points P3 which we chose to represent pre-peak myelination, and P7 which 
we chose to represent peak myelination. For our differential expression analyses, 
we found that 677 of the 1389 putative QKI gene targets were differentially 
expressed between P3 compared to P7 (p<0.05, Student’s t-test, unpaired). We 
chose to look at the genes that have the largest differential expression, so we 
showed the Top 15 Up-regulated Genes in P3 compared to P7 and the Top 15 
Up-regulated Genes in P7 compared to P3 (Table 5.3.1). Each list of 15 were 
acquired via ranking of absolute fold change. The genes were the subsequently 
sorted by significance. Using gene enrichment analysis via DAVID, we found that 
the top biological processes represented by the 30 combined genes were 





Table 5.3.1: Top differentially expressed putative QKI target genes  
Top 15 Up-regulated putative QKI target genes in P3 compared to P7 
Symbol Name FC P 
value 
Tgtp1† T cell specific GTPase 1 16 0 
Il7† interleukin 7 11 0 
Tgtp2† T cell specific GTPase 2 15 0.001 
Magel2 melanoma antigen, family L, 2 6 0.001 
Ccr3 chemokine (C-C motif) receptor 3 6 0.001 
Cd28† CD28 antigen 5 0.002 
Col10a1 collagen, type X, alpha 1 23 0.009 
C1qtnf3 C1q and tumor necrosis factor related protein 3 5 0.01 
Chrna6 cholinergic receptor, nicotinic, alpha polypeptide 6 16 0.01 
Cxcl9† chemokine (C-X-C motif) ligand 9 63 0.01 
Irf7 interferon regulatory factor 7 -6 0.01 
Isg15 ISG15 ubiquitin-like modifier 7 0.01 
Gbp2 guanylate binding protein 2 5 0.03 
Krt71 keratin 71 7 0.04 
Ndst4 N-deacetylase/N-sulfotransferase 4 4 0.04 
 
Top 15 Up-regulated putative QKI target genes in P7 compared to P3 
Symbol Name FC P 
value 
Gcg glucagon 5 0 
Mbp* myelin basic protein 3 0 
Mal* myelin and lymphocyte protein 3 0 
Gjb1 gap junction protein, beta 1 3 0.001 
Ugt8a* UDP galactosyltransferase 8A 3 0.001 
Galr1 galanin receptor 1 5 0.001 
Krt12 keratin 12 3 0.002 
Myl1 myosin, light polypeptide 1 3 0.002 
Plp1* proteolipid protein 1 3 0.007 
Ear1 eosinophil-associated, ribonuclease A family, 
member 1 3 0.009 
Otop1 otopetrin 1 4 0.01 
Il23a† interleukin 23, alpha subunit p19 4 0.01 
Mobp myelin-associated oligodendrocytic basic protein 6 0.01 
Emilin2 elastin microfibril interfacer 2 3 0.01 
Cyp26a1 cytochrome P450, family 26, subfamily a, 






Our differential expression analyses of the putative QKI-RBP target genes 
indicate that knockout of QKI at pre-peak or peak myelination can affect different 
groups of target genes leading to diverging phenotypic consequences. After 
looking at the molecular and ultrastructural characteristics of the pre-peak 
myelination and peak myelination time points in CBA/CaJ mouse AN, we chose 
to induce qkI KO either beginning at P5 (Group 1) or at P7 (Group 2). The P5 
time point was chosen to represent pre-peak myelination group in order to 
increase viability of the TAM injected pups.  
 
 
5.3.2 Abrogation of QKI RBP expression in myelinating glial cells after 
knockout of qkI gene 
After looking at the molecular and ultrastructural characteristics of the pre-
peak myelination and peak myelination time points in CBA/CaJ mouse AN, we 
chose to induce qkI KO either beginning at P5 (Group 1) or at P7 (Group 2). The 
P5 time point was chosen to represent pre-peak myelination group in order to 
increase viability of the TAM injected QKIFL/FL;PLPCreERT  and littermate control 
pups. The Plp1 promoter in the PLPCreERT mouse used to for the qkI deletion 
was shown to be present in SGCs and SCs of mouse ANs14. In Chapter 4 
(Figure 4.3.4) we showed that Pan-QKI is expressed in AN SCs and SGCs. 
Based on Pan-QKI and Plp1 protein expression, the QKIFL/FL;PLPCreERT model 
should only deplete qkI in AN glial cells.  Figure 5.3.2 A shows a schematic 

























Figure 5.3.2: Abrogation of QKI RBP expression in myelinating glial cells 
after knockout of qkI gene 
 
A The schematic shows the induction time points for the qkI KO and 
experimental outline for the following experiments. Group 1 included mice that 
were injected at P5 (pre-peak myelination). Group 2 included mice that were 
injected at P7 (during peak myelination). The groups were then further divided – 
animals from each group were tested for ABR and their ANs were harvested at 
either P14 or P20/21. B This is a schematic of a cochlear section showing the 
main components of the auditory nerve. C-Z These panels show effect of qkI KO 
for subjects from Group 1 (C-N) and Group 2 (O-Z). Cochlear sections were 
stained with Sox10 (green) to indicate SCs and SGCs, Pan-QKI (red) antibody 
was used to stain for all QKI-RBPs, and nuclei were counterstained with DAPI 
(blue). C-E and O-Q show presence of Pan-QKI in Sox10+ glial cells in P14 QKI-
Ctrl mice from either induction group. Asterisks indicate representative cells with 
Sox10/Pan-QKI expression. F-G, R-T show ablation of Pan-QKI in Sox10+ glial 
cells in Group 1 (F-G) and Group 2 (R-T) P14 QKI-KO. White arrowheads 
indicate representative glial cells that have no Pan-QKI reactivity. I-K, U-W show 
presence of Pan-QKI in Sox10+ glial cells in Group 1 P20 (I-K) and Group 2 P21 
(U-W) QKI-Ctrl ANs. White arrow heads indicate Asterisks indicate 
representative cells that are Sox10+/Pan-QKI+. Black arrowheads indicate 
representative cells in the AN that are Pan-QKI+, but not Sox10+. L-N, X-Z show 
abrogation of Pan-QKI expression in Group 1 P20 (L-N) and Group 2 P21 (X-Z) 
QKI-KO Sox10+ cells. White arrowheads indicate representative glial cells that 
have ablated Pan-QKI expression. Asterisks mark the few Sox10+/Pan-QKI+ cells 












We measured ABRs and collected ANs from each group at P14, which is 
around the onset of hearing, and at P20/21, which is around the period when the 
AN should be functionally mature based on our studies in Chapter 3. Figure 
5.3.2 B shows a cartoon of a cochlear section highlighting the regions of interest 
for our study. Most of our confocal and TEM images were focused on the Hab, 
OSL, and RC regions of the AN.  
Before proceeding with our morphological and physiological studies, we 
needed to investigate the effectivity of our qkI KO in the AN glial cells. We 
performed co-immunostaining experiments with anti-Sox10 and anti-Pan-QKI, 
which detect all QKI variants, on our P14 and P20/21 cochlear sections. Sox10 is 
a marker for both SCs and SGCs151 in the AN. Immunohistochemical analyses 
show that the qkI KO was successful in depleting QKI-RBPs in P14 and P20/21 
AN glial cells for both QKI-KO groups compared to littermate QKI-Ctrls. In the 
P14 QKI-KO, presence of QKI-RBP in both SCs and SGCs were ablated for both 
groups (Figure 5.3.2 C-H; O-T). For the P20/21 animals for both groups, most of 
the Sox10+ cells in the AN had no reactivity for anti-Pan-QKI (Figure 5.3.2 I-N; 
U-Z). There were only few Sox10+ cells in the AN that were positive for QKI-RBP 
expression. Based on our findings in Chapter 4, we concluded that these were 
SGCs and not SCs. In the KO animals, the few Sox10+ cells that were Pan-QKI+ 
were only present in the RC and not the OSL, and their morphology and 
attachment around the SGN somata indicate that these were SGCs. We also 
saw cells that were Pan-QKI+ but are negative for anti-Sox10 reactivity. We 
concluded that these were not type I SGNs as supported by previous literature128 
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and because of the differing morphological characteristics between the cells that 
are Sox10-/Pan-QKI+ and SGNs. Other cells that reside among the SGNs and 
glial cells, which these Sox10-/Pan-QKI+/DAPI+ cells may be, include 
macrophages (as we show in Chapter 4 and Figure 5.3.4-6) and fibroblasts173. 
Co-immunostaining of Pan-QKI with macrophage and fibroblast markers could be 
executed in future experiments to identify these cells. These findings show that 
our qkI KO and the subsequent depletion of QKI-RBP variants in both groups 
was sufficiently effective.   
 
 
5.3.3 Developmental-stage dependent QKI-KO induces hypomyelination or 
dysmyelination of AN fibers at P14 
The best way to visualize the effects of the qkI KO in the QKI-KO AN 
compared to QKI-Ctrl is to look at the ultrastructure via TEM. In this way, we 
could determine the consequence of the KO on the ability of the auditory glial 
cells to myelinate the AN fibers and somata. We first looked at the AN 
ultrastructures at the P14 endpoint. As we saw in association with the node 
studies in Chapter 3, the SGN fibers and, to a lesser extent, the somata, are 
ensheathed by compact, multi-layered myelin by P14 in parallel with the onset of 
hearing. Here we show that the QKI-Ctrls for Group 1 (Figure 5.3.3 A-C) and 
Group 2 (Figure 5.3.3 G-H) have dense myelination around their axons and have 
at least one layer of myelin lamella around their somata. We found in our studies 
in Chapter 3 that myelination around the somata by the SGCs is slower 







Figure 5.3.3: Developmental-stage dependent QKI-KO induces 
hypomyelination or dysmyelination of AN fibers at P14 
 
The majority of AN fibers and soma lack dense myelination in P14 QKI-KO ANs 
(D-F) compared to littermate controls (A-C) when QKI deficiency is induced at 
P5. Compact myelin enwraps P14 QKI-KO axons when deficiency is induced at 
P7 (I), but dysmyelination occurs at the soma (J) compared to Group 2 littermate 
controls (G,H). A-F Ultrastructure of AN fibers in P14 QKI-Ctrl (A-C) and P14 
QKI-KO (D-F) induced at P5. Transverse (A, D) and coronal (B, E) sections of 
type I SGN axons in OSL and soma (C,F) in RC. A,D Asterisks indicate SCs; 
white arrows indicate densely myelinated fibers. D White arrowheads indicate 
representative axons wrapped by a layer of cytoplasm-filled SC process. B A 
white arrow points to a representative axon that is densely myelinated. E White 
arrowheads indicate axons each ensheathed bysingle SC layer. A white arrow 
marks an example of the small number of densely myelinated fibers. C A white 
arrow shows a condensed myelin layer surrounding QKI-Ctrl soma. F A white 
arrowhead shows cytoplasm-filled SGC process wrapping around QKI-KO soma. 
G-H Ultrastructure of AN fibers in P14 QKI-Ctrl (G,H) and P14 QKI-KO (I,J) 
induced at P7. G,I show densely myelinated axons present in both QKI-Ctrl and 
QKI-KO. White arrows indicate representative fibers with dense myelination. H 
White arrows mark compact myelin layers surrounding QKI-Ctrl soma. J White 
arrowheads mark a loose myelin layer detaching from the soma; asterisks 





The reduction of cytoplasm within the ensheathing myelin lamella, as we see 
around the somata in Figure 5.3.3 C and H, is a sign of compact myelin 
development174. In stark contrast to the QKI-Ctrls, we saw prevalent 
hypomyelination of the axons (Figure 5.3.3 D-E) and somata (Figure 5.3.3 F) in 
the Group 1 P14 QKI-KO. The majority of the Group 1 QKI-KO axons were 
wrapped only by thick, cytoplasm-filled SC processes. Only few axons were 
ensheathed by compact myelin. The membranes of somata were covered by a 
single thick SGC processes, if at all. The qki KO in P5 has impaired glial function. 
The under-developed myelin around these SGNs can either indicate that 
myelination during early postnatal AN development is delayed in Group 1 QKI-
KO or if hypomyelination persists in later time points, glial dysfunction may be 
more severe.  
 Contrary to our findings in Group 1 QKI-KO, the axons of the Group 2 
QKI-KO are densely myelinated (Figure 5.3.3 I) similar to their QKI-Ctrl 
counterparts. Upon closer visual inspection of our TEM image sets showing 
transverse sectioning of the fibers, however, we could argue that the dense 
myelin around the QKI-KO animals may be thinner compared to QKI-Ctrl. To 
solidify this suspicion, we will complete G ratio measurements for this group, as 
divergence from the optimal G ratio (~0.6 in PNS fibers) are associated with 
aberrant conduction175–177. In contrast to the subtle differences myelin difference 
between Group 2 QKI-KO and QKI-Ctrl, qkI KO-induced dysfunction of the SGCs 
is clearer. In Figure 5.3.3 J, the enwrapping myelin is looser and detaching from 
the soma in several places in the QKI-KO. Dysmyelination around the somata 
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strongly implies that qkI KO in P7 affects the glial cells’ ability to maintain 
myelination as opposed to the qkI KO in P5 which may affect the glial cells’ ability 
to create myelin.  
  
 
5.3.4: qkI KO at P5 leads to chronic hypomyelination and morphologically 
abnormal SCs 
We continue our ultrastructural studies by analyzing at the effects of qkI 
KO in pre-peak myelination P5 at a later endpoint. The period around P20-21 is 
associated with AN structural and functional maturation. Very recent studies have 
shown that type I SGN differentiation into their mature subtypes, which are 
associated with their distinguishing firing properties, occur at around the third 
postnatal development week105–107. As we have reviewed in Chapter 1, these 
SGN subtypes have different SRs that contribute to the canonical wave I 
response seen in functionally mature ANs8,9,104 (i.e., the ability of the different 
subtypes to be recruited for a greater summed response at higher intensity 
stimulation and the continued response of high SR fibers in low intensity stimuli). 
Previous studies86, along with our own, (Appendix A-1) show that threshold and 
suprathreshold measurements of amplitude and latency from mice ≥P18 are 
comparable to those of young-adults.  
 In these studies, we show that hypomyelination of the SGN axons and 


















Figure 5.3.4: qkI KO at P5 leads to chronic hypomyelination and 
morphologically abnormal SCs  
 
The majority of AN fibers and soma in Group 1 mice with qkI KO induced at P5 
were still hypomyelinated compared at P20 (F-J) compared to their littermate 
controls (A-E). A shows a white arrow pointing to one densely myelinated AN 
fiber in QKI-Ctrl. This is representative of the fiber population in the QKI-Ctrls. F 
shows a white arrowhead indicates a representative hypomyelinated fiber in QKI-
KO. A white arrow points to one of the few densely myelinated fibers. B and the 
enlargement C show a SGN somata that are enwrapped by multiple layers of 
SGC myelin. The white arrows point to the dark, electron-dense myelin lamellae. 
G shows multiple hypomyelinated somata in QKI-KO. The white arrowheads 
indicate two somata enwrapped by a few layers of cytoplasm-dense SGC 
processes. The white arrow points to one of the small number of somata that are 
ensheathed by multiple layers of myelin. The enlargement H highlights the two 
layers of SGC processes enwrapping a soma compared to the dark, eletron-
dense myelin lamellae enwrapping another soma. D,E and I,J show heminodes 
at the habenula in QKI-Ctrl (D,E) and QKI-KO (I,J) ANs. The heminodes of 
control AN are densely myelinated on their processes running along the OSL. 
The enlargement E further highlights thick myelination. A white arrow indicates 
an example heminode and its associated paranodal domain. A white arrowhead 
points to an example fiber that is naturally unmyelinated after the heminode in 
order to easily pass through the hab to synapse with the HC. Compared to 
control, the QKI-KO at the habenula shows many fibers that are only ensheathed 
by one SC process (I). The white arrow points to a heminode of one myelinated 
AN fiber. Notice how far this heminode is from the habenula compared to the 
heminodes in D. The enlargement J highlights the thoroughly hypomyelinated 
fibers (white arrowhead marks a representative fiber) which do not have 
heminodes, much less paranodal domains. K,L highlight the presence of 
macrophages in P20 QKI-KO. The black asterisk in K marks the nucleus of a 
macrophage with many ramification (black arrowhead). The black asterisk in L 
indicates an ameboid-shaped macrophage filled with multiple vesicles. The black 
arrowhead points to a macrophage process approaching an apoptosed SGN 
fiber (grey asterisk) that also shows signs of dysmyelination. Panels M-O show 
examples of morphologically abnormal SGCs. The white arrowheads indicates 
detachment of the SGC processes from the somata, which also appear to have 
multiple leading ends proceeding away from the somata membranes (especially 
highlighted in O). The black asterisk in M is an example of an ameboid-shaped 
macrophage next to a soma. Notice the similar morphology of this macrophage 






In contrast to the thickly sheathed axons of QKI-Ctrl (Figure 5.3.4 A), the 
majority of the axons of QKI-KO are still only enveloped by a cytoplasm-filled SC 
process (Figure 5.3.4 F). Although there are axons with multi-layered myelin, 
only a small number of them match the myelin volume seen in controls. 
Comparison between fiber myelination here and in P14 QKI-KO (Figure 5.3.3 D) 
may indicate that the qkI KO may lead to further decline in axo-glial attachment. 
The lone SC process surrounding the axon in P20 QKI-KO are not snugly 
apposed to the axolemma and spaces of separation are visible. Most of the SGN 
somata in QKI-KO are also shrouded by few layers of compact myelin or a few 
turns of SGC processes with condensed cytoplasm (Figure 5.3.4 G, H 
enlargement) compared to the dense myelination of control somata (Figure 5.3.4 
B, C enlargement). The enlargement in Figure 5.3.4 H highlights one of the 
small number of somata enwrapped by multi-layered myelin and the prevalent 
state of SGC myelination seen in QKI-KO, which is shrouding of somata by non-
compact SGC processes/lamellae. This can be defined as a sort of 
“intermediate/immature” myelination, where the SGC processes have expelled 
their cytoplasm in preparation for tight compaction of the layers.  
 We also looked at the habenular region where the heminodes reside and 
cluster. In normal mice and in the controls we show here (Figure 5.3.4 D, F 
enlargement), the SC most distal to the somata terminates its myelination of the 
axon at the heminodal paranode, which is located towards the OSL. After the 
heminode, the SGN is naturally un-myelinated in order to pass through the small 
opening of the hab to synapse with the IHC. The most distal SCs still provide 
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thick myelination to the axons at the end of the OSL prior to the hab opening. 
Clustering of heminodes at the hab reveal many excitable heminodal 
domains/axon initial segments and termination of the myelin lamellae at the 
heminodal paranode domains. We show that the P20 QKI-KO have largely 
hypomyelinated fibers at the hab, as no heminodal paranodes are visible at the 
opening (Figure 5.3.4 I, J enlargement). Clustering of heminodes may also be 
abnormal as one of the few fibers with a visible heminodal paranode is much 
further out into the OSL compared to QKI-Ctrl.  
 Ultrastructural analyses of Group 1 ANs also revealed ubiquity of cochlear 
macrophages (Figure 5.3.4 K,L). The macrophages present had different 
morphologies. Some were elongated and had multiple ramified processes 
(Figure 5.3.4 K). Others were ameboid-shaped and were filled with multiple clear 
vesicles (possibly lysosomes) and had many dark organelles (possibly 
mitochondria) (Figure 5.3.4 L). Macrophages are naturally present in the cochlea 
to phagocytose debris. Similar to CNS microglia, resident macrophages present 
among the SGNs have a ramified appearance, which are attributed to their 
surveying of the environment for debris178–180. These elongated, ramified 
macrophages are thought to be in a “resting” state. Recruitment and infiltration of 
macrophages can occur in the cochlea after injury, as others have found143,146 
and as we have shown in Chapter 4. “Activated” macrophages phagocytosing 
debris and apoptotic cells have been characterized as having an “ameboid-
shape178,181.” Aside from macrophages, SCs also function to clear debris in the 
PNS via autophagy and phagocytosis182,183. In Figure 5.3.4 L, we see an SC that 
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has phagocytosed multiple myelin whorls and diseased axons, while also 
functioning to shroud a healthy, large diameter axon.  
Our studies also reveal that SGCs juxtaposed to the somata have 
abnormal morphology (Figure 5.3.4 M-O) compared to those seen in QKI-Ctrl. 
Instead of being closely conformed and attached to the somata, these SGCs take 
on a globular, un-healthy-looking appearance. At times it may be hard to 
distinguish them from activated cochlear macrophages, as evidenced in Figure 
5.3.4 M. These SGCs are more detached from the somata and have processes 
spreading away from the soma membrane. These processes may simply be 
detaching from each other or the soma membrane due to lack of glial-glial or 
glial-soma adhesion molecules. Another explanation could be that they may be 
responding to and being attracted towards an environmental signal, similar to 
how macrophages respond to cytokines.  
 
 
5.3.5 Eventual dysmyelination of type I SGN fibers and somata in P21 after 
qkI KO at P7 
In parallel with out ultrastructural studies for Group 1, we analyzed P21 
QKI-KO in comparison with age-matched QKI-Ctrl. Our QKI-Ctrl had thick 
myelination around the axons (Figure 5.3.5 A), and around the soma (Figure 
5.3.5 B, C enlargement). In contrast, we observed a range of myelination 
around the QKI-KO axons (Figure 5.3.5 D). Some maintained their dense, 
compact myelin, while many were shrouded by a single layer SC process. 
Dysmyelination of some SGNs is evidenced by visible separation within compact 
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myelin layers. There were also signs of SGN degeneration, as shown by a thin 
myelin layer surrounding a large empty space where a fiber should be. The size 
of the space, in comparison to the diameter of surrounding axons, as well as the 
roundness of the remaining myelin, imply that the space may be edematous. 
SGN abnormalities can also be indicated by the presence of abnormally 
abundant dark vacuoles/organelles within the cytoplasm, implying that axonal 
transport mechanisms could be compromised64. The majority of the somata were 
not enwrapped by multi-layered, compact myelin compared to QKI-Ctrl. 
Dysmyelination of the somata (Figure 5.3.5 E, F enlargement) has also 
worsened in P21 QKI-KO compared to P14 QKI-KO (Figure 5.3.3 J). 
Separations between SGC myelin lamellae and detachment from the soma 
membrane are apparent.  
 Disruption of the axo-glial connections at the paranodal domains in P21 
QKI-KO was also present (Figure 5.3.5 G,H). Compared to the paranodal 
structure seen in QKI-Ctrl (Figure 5.3.5 A), terminal myelin loop layers had 
spacious separations between each other. This further implies a possible 
depletion of glial-glial adhesion molecules. Other terminal myelin loops either lost 
or had no initial connection to the axolemma or were severely misconnected, as 
seen in Figure 5.3.5 H. This could indicate decreased expression of axo-glial 
connector molecules or abnormal signaling promoting myelin deposition between 









Figure 5.3.5: Eventual dysmyelination of type I SGN fibers and somata in P21 
after qkI KO at P7  
 
Dysmyelination of the fibers and somata are evident in the Group 2 P21 QKI-KO 
mice (D-F, G-H) compared to the densely myelinated type I SGNs in QKI-Ctrl (A-
C). A is a representative image showing that the majority of the QKI-Ctrl fibers 
are ensheathed by multiple layers of compact myelin. The white arrow points to a 
representative densely myelinated fiber. A black arrow points to a paranodal 
domain with multiple, snuggly apposed terminal myelin loops connected to the 
axolemma. D shows multiple QKI-KO AN fibers with different stages of 
myelination. A white arrow indicates a myelinated fiber. A white arrowhead points 
to a fiber ensheathed with a single layer of thick SC process. A black arrow 
indicates a fiber with abnormal separations within its compact myelin. A grey 
asterisk points to a thin myelin layer enwrapping a space where the fiber process 
of an apoptosed SGN resided. A black asterisk marks an example of an SGN 
fiber filled with small, dark, electron-dense vacuoles. B and the enlargement C 
shows an example of a control soma with multi-layered myelin (highlighted with 
white arrows) that is further surrounded by a thicker layer of SGC process (black 
arrowhead in C). (E, F) Compared to control, the soma of QKI-KO fibers are 
surrounded by fewer SGC lamellae (indicated by white arrowhead in E) that are 
also detaching from each other (indicated by black arrowhead in F), as well as 
the soma membrane. A black asterisk in E highlights another dark vacuole-filled 
SGN fiber. G,H show disruption of the axo-glial connections and glial-glial 
connections at the paranodal domain compared to the one seen in control (A). 
The white arrowheads point to the abnormal spacing in between terminal myelin 
loop heads. The white arrow in G highlights a loophead detached from the 
axolemma and the one in H points to a loop head that has unusually extended to 
surface with the axolemma, blocking connections of other terminal loop heads in 
the process. I shows ameboid-shaped macrophages within a blood vessel (white 
asterisks) and one with long processes (black arrowhead) that has crossed to the 
RC (black asterisk). The black arrow points to one of the many elongated 
macrophage processes seen in this panel. J shows another ameboid-shaped 
macrophage (black asterisk) with processes (black arrowhead) approaching an 









Similar to findings in P20 Group 1 QKI-KO, Group 2 QKI-KO also revealed 
ubiquity of cochlear macrophages (Figure 5.3.5 D,I,J). These macrophages, 
which are either ramified or ameboid in shape, can be found among degenerative 
SGNs. Macrophages can also be seen coming into the cochlear RC space from 
the blood vessels (Figure 5.3.5 I), which may imply their active recruitment by 
either the dysfunctional glia or degenerating SGNs. Together with the 
ultrastructural analyses at P14, these findings show that although myelinating 
glial cells with qkI KO were capable of creating multi-layered myelin around 
SGNs, they were unable to maintain the myelin integrity at later endpoints.  
 
5.3.6 MBP expression is chronically depleted and Iba+ cells are present in 
great numbers adjacent to dysmyelinated somata in either qkI KO group 
To elucidate the dysmyelination we saw in the ultrastructure at the 
molecular level, we performed immunohistochemical studies to with anti-MBP 
and anti-Iba1. We reviewed in Chapters 1 and 3 the importance of myelin basic 
protein (MBP), which is one of the main structural components of myelin 
membranes94 and also a marker of matured myelinating glial cells27. MBP mRNA 
contains QREs and is a known target of QKI-RBPs56,58,130. Besides affecting 
localization of MBP mRNA, studies have shown that exogenous QKI-6 
introduced into the quaking viable mice binds to MBP mRNA and is associated 
with rescuing myelinogenesis and the maintenance of compact myelin130. We 












Figure 5.3.6: MBP expression is chronically depleted and Iba+ cells are 
present in great numbers adjacent to dysmyelinated somata in either qkI KO 
group 
In both Group 1 and 2, QKI-Ctrls have MBP (green) expression present in both 
earlier (P14 A,B; I,J) and later (P20 G,H; P21 O,P) endpoints. MBP is present 
together with the long axonal processes and surrounding the somata. In the Group 
1 P14 QKI-KO (C,D), there is almost no MBP surrounding the somata. In Group 2 
P14 QKI-KO (K,L), MBP expression is a little more apparent in the RC compared 
to Group 1, but there are no somata surrounded by complete MBP expression. 
Sparse, disjointed expression of MBP around the somata are indicated by the 
white arrowheads in C,D and K,L. (G,H) In Group 1 P20 QKI-KO, there is a smaller 
number of axons that have MBP expression along the axons compared to the age-
matched control (E,F), as well as to the Group 1 P14 QKI-KO. The white 
arrowheads in G,H indicate one of the few somata surrounded by MBP expression. 
(O,P) In Group 2 P21 QKI-KO, MBP expression continues to be depleted 
compared to the age-matched control (M,N). The white arrowheads in M,N indicate 
one of a small number of somata that are surrounded by MBP expression. Double-
labeling with Iba1+ macrophages (red) show that both amoeboid and ramified 
macrophages are present in large quantities in the RC of the QKI-KO ANs at either 
endpoint for both groups (P14 D,L; P20/21 H,P) compared to their controls (P14 
B,J; P20/21 F,N). The macrophages can be found adjacent to the sparse MBP 
expression around the somata and juxtaposed to somata not surrounded by MBP. 














Since myelination of axons and somata can be identified at the RC, we 
chose to focus on that region with our analyses. Our immunostaining 
experiments reveal that compared to P14 QKI-Ctrls which had MBP expression 
along the axons and around the somata (Figure 5.3.6 A,B), the Group 1 P14 
QKI-KOs showed reduced MBP expression along the axons and especially 
around the somata (Figure 5.3.6 C,D). There were few, if any, SGNs that had 
MBP completely surrounding their somata. Although, disjointed anti-MBP 
immunoreactivity can be seen around the vicinity of the SGN cell bodies. Group 2 
P14 QKI-KO (Figure 5.3.6 K,L)  had similar MBP expression along their axons 
compared to their controls (Figure 5.3.6 I,J). Around the somata, however, MBP 
expression was visibly reduced, although not to the same extent as in Group 1.  
By the later endpoint at P20/21, MBP expression for both KO groups 
continue to be depleted surrounding the somata (Figure 5.3.5 G,H; O,P)  
compared to their respective controls (Figure 5.3.5 E,F; M,N). Compared to 
Group 1 QKI-KO, Group 2 QKI-KO had more SGNs with immunoreactivity to anti-
MBP encompassing their cell bodies. In Group 1, only a small number of SGN 
cell bodies that were shrouded by MBP expression. It appears that MBP 
expression along the axons are also further reduced. To bolster these 
experimental findings and to determine if qkI KO is affecting either MBP mRNA 
translation efficiency or its stability, we could compare levels of MBP mRNA in 
the QKI-KO AN with MBP expression. This could be done via combination of RT-
qPCR and western blots or comparing intensities of fluorescent MBP in situ with 
MBP immunofluorescence.  
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To further our ultrastructural findings pertaining to cochlear macrophages 
in association with dysmyelination, we performed co-immunostaining for MBP 
with Iba1. Our findings show that both ramified and amoeboid macrophages are 
largely present surrounding the SGN cell bodies in QKI-KO at either endpoint for 
both groups (Figure 5.3.6 D,H; L,P). In the QKI-Ctrls (Figure 5.3.6 B,F; J,N), 
macrophages are also visible, but in much lesser quantities. To comment on 
possible activity, compared to the QKI-KOs, most of these macrophages in QKI-
Ctrl have an elongated, ramified shape, which implies that they are in their 
“resting” state. To extend these studies, we could perform morphometric 
analyses on these Iba1+ macrophages, in which number of processes and cell 
shape and volume will be measured and compared between QKI-KO and QKI-
Ctrl. We can also co-label Iba1 with markers of actively phagocytosing 
macrophages, such as CD11b and CD6879,186–188 to functionally differentiate the 
macrophages present in QKI-KO compared to QKI-Ctrl.  
 
5.3.7 qkI KO caused abrogated Cntn1 expression and disruption of 
paranodal structures 
We saw earlier in the ultrastructural studies shown in Figures 5.3.4-5 that 
the integrity of nodal structures were compromised in after qkI KO. To further 
elucidate the effects of qkI-KO on the nodal domains and to understand which 
molecules may be affected, we performed immunohistochemical experiments 




























Figure 5.3.7: qkI KO caused abrogated Cntn1 expression and disruption of 
paranodal structures 
 
Immunostaining of nodal NrCAM (red) and paranodal Cntn1 (green) in AN 
sections from QKI-KO induced at either P5 (D-F) or P7 (P-R) shows that 
disruption of paranodal structures of all 3 nodal types is apparent in both 
experimental groups compared to controls at P14 (A-C; M-O). The abrogated 
expression of Cntn1 continues into later development for both QKI-KO groups 
(Group 1 J-L; Group 2 V-X) compared to their controls (G-I; S-U), indicating that 
disruption at the paranodal domain is also chronic. Throughout this figure, white 
arrows mark representative, normal paranodal domains with Cntn1 expression at 
the single paranode of the heminodes (Group 1 A,G; Group 2 M,S), in paranodal 
flanks of the axonal nodes (Group 1 B,H; Group 2 N,T) and at the ganglion 
paranodes (Group 1 C,I; Group 2 O,U). For the Group 1 panels, white 
arrowheads mark representative nodal structures without Cntn1 expression at 
the paranodes for the P14 endpoint (D-F), continuing to the P20 endpoint (J-L). 
The white arrowheads marking the Cntn1- heminodes in D,J also highlight the 
disorganization of heminodal clustering under the IHC, as several of the 
heminodes are further out into the OSL. Cntn1 expression at the paranodes in 
Group 2 is not completely abrogated in all paranodes of the heminodes (P) and 
axonal nodes (Q) at P14, but are greatly reduced compared to their control 
counterparts (M,N). Black arrowheads in P,Q indicate paranodes with some 
presence of Cntn1. For the ganglion paranodes, however, Cntn1 expression is 
depleted at P14 (R), continuing to P21 (X) compared to their controls (O,U). By 
P21, Cntn1 expression at the heminodes (V) and axonal nodes (W) of Group 2 
ANs have greatly diminished compared to the age-matched controls (S,T) and 
Group 2 P14 QKI-KO. As with the Group 1 QKI-KO heminodes, the positioning of 
Group 2 heminodes (highlighted by white arrowheads) show un-clustered and 
scattered heminodes. Nodal NrCAM expression is intact in P14 QKI-KO for both 
groups, but by P20/21, their usually cylindrical appearance is harder to 










To briefly recap previous literature36,189 and our findings in Chapter 3, 
NrCAM is associated with initiation of formation of the excitable nodal domains 
and is responsible for binding the scaffolding proteins responsible for VGSC 
clustering at the node. Axolemmal Cntn1 and Caspr1 work together to bind glial 
Nfasc155 present at the terminal myelin loop heads to form organized, well-
connected axo-glial connections at the paranode41,42. Nfasc155 is a known QRE-
containing target of QKI-RBPs and KO of qkI has been shown to impair 
generation of Nfasc15559.  
To begin, we found that Cntn1 protein is expressed normally in the 
paranodes of the heminodes, axonal nodes, and ganglion nodes of the QKI-Ctrls 
at either endpoint (Figure 5.3.7 A-C, G-I; M-O, S-U), comparable to their 
immunofluorescence profiles that we determined in Chapter 3. In Group 1 QKI-
KO, Cntn1 expression was completely ablated in the heminode and ganglion 
node paranodes, while greatly reduced expression can be detected in the 
paranodal flanks of the axonal node (Figure 5.3.7 D-F). At P20, Cntn1 is barely 
detectable in any paranode (Figure 5.3.7 J-L), implying that abrogated Cntn1 
expression is chronic.  
In the Group 2 P14 QKI-KO, Cntn1 expression is more detectable 
compared to Group 1 P14 QKI-KO, with Cntn1 present at heminodal and axonal 
paranodes (Figure 5.3.7 P-R). However, expression is still greatly reduced 
compared to control, and no Cntn1 can be detected at the ganglion paranodes. 
By P20, Group 2 QKI-KO have no observable Cntn1 in any paranodal type 
(Figure 5.3.7 V-X). Based on our compiled list, Cntn1 is not a direct target of 
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QKI-RBPs. However its significant depletion after qkI KO strongly suggests that it 
is at least an indirect target of QKI-RBPs.  
Additionally, while anti-NrCAM immunoreactivity is comparable to that of 
QKI-Ctrls in both P14 QKI-KO groups, its usual cylindrical staining profile is 
harder to distinguish in heminodes and axonal nodes of both P20 QKI-KO 
groups. This implies that continued glial dysfunction affects axonal organization 
or expression of this nodal CAM. Anti-NrCAM staining of the heminodes at the 
habenula for either group (Figure 5.3.7 D,J; P,V) also exemplifies 
disorganization of the heminodal clusters in QKI-KO compared to controls 
(Figure 5.3.7 A,G; M,S). Unlike in the QKI-Ctrls where anti-NrCAM staining is 
clustered at the hab, -each QKI-KO panel displays separation of anti-NrCAM 
immunoreactivity and marks heminodes that are further out towards the OSL. 
This further suggests dysregulation of NrCAM localization at in the distal portion 
of the axons towards the hab after qkI KO.  
  
 
5.3.8 qkI KO-induced hypomyelination leads to loss of AN function 
 
To determine if chronic hypomyelination and the associated nodal 
structural aberrations caused by qkI KO at P5 can affect AN function, we 
performed ABR tests to measure threshold and suprathreshold responses. Our 
threshold measurements at P14 (Figure 5.3.8 A) show that QKI-KOs have 
greatly reduced sensitivities to pure tone stimuli across frequencies compared to 
QKI-Ctrls. Most QKI-KO mice tested at P14 had no response to any stimuli, so 





Figure 5.3.8: qkI KO-induced hypomyelination leads to loss of AN function 
 
Trends of AN wave I threshold and suprathreshold measurements for the Group 
1 KO mice showed increased thresholds, longer peak latencies, decreased 
synchrony, and diminished amplitudes compared to age-matched controls. A and 
B plot the thresholds of response (in dB SPL) across low to high frequency pure 
tone stimuli. Error bars indicating mean SEM are shown for each data point. A 
shows P14 QKI-KO animals have higher thresholds, if they responded at all 
compared to P14 QKI-Ctrl (n = 7 mice/7 ears for KO, n = 9 mice/9 ears for Ctrl). 
B shows that both groups at P20 had lower thresholds compared to P14, but that 
thresholds from QKI-KO animals were higher across all frequencies compared to 
QKI-Ctrl (n = 3 mice/3 ears for KO, n = 6 mice/6 ears for Ctrl). C shows the 
averaged ABR waveforms for P20 QKI-KO versus QKI-Ctrl animals stimulated at 
90dB SPL intensity at 11.3kHz. Lighter vertical bars show mean SEM across 
data points for each group. Compared to QKI-Ctrl, the QKI-KO waveform clearly 
shows a lower and delayed wave I peak. Wave I is also wider for the QKI-KO 
compared to QKI-Ctrl. D-F plot the suprathreshold wave I responses from 90-70 
dB SPL stimuli at 11.3kHz from P20 mice (n = 3 mice/6 ears for KO, 6 mice/12 
ears for Ctrl). Regression lines are plotted for each group. D shows that peak 
latencies are longer in QKI-KO compared to control. (C) Synchrony of AN 
response as measured by mean PLV is decreased in QKI-KO animals compared 
to controls. (F) peak amplitudes measurements show that QKI-KO animals 




By P20, thresholds of QKI-KO mice were lower (Figure 5.3.8 B), indicating that 
they actually developed hearing sensitivity over time. However, their thresholds 
across all tested frequencies were higher compared to QKI-Ctrls. Looking at the 
averaged waveform responses at 90 dB SPL (Figure 5.3.8 C), we see that 
compared to QKI-Ctrls, the AN wave I response of QKI-KOs were lower and 
delayed. The width of wave I was also wider in the QKI-KOs which can indicate 
dyssynchrony of AN fiber firing. Our suprathreshold measurements (Figure 5.3.8 
D-E) show that the peak latencies of QKI-KO were much longer compared to 
QKI-Ctrls as seen by the wide separation between the data points and regression 
lines. Mean PLV, our measure of AN synchrony across trials, show that AN 
synchrony was decreased in the QKI-KOs compared to controls. Peak amplitude 
measurements across levels also showed a trend towards decrease in QKI-KO 
compared to QKI-Ctrls. Chronic hypomyelination, coupled with un-clustered 
heminodes and reduced integrity of axo-glial connections at the paranodal 
domains are implicated in our pathophysiological findings, especially in the 




5.3.9 Eventual dysmyelination due to qkI KO at peak myelination may lead 
to functional declines in later development 
In parallel with our physiological studies for Group 1, we decided to test 
ABRs on our Group 2 animals with the qkI KO at P7 during peak myelination. 
Our results for the suprathreshold measurements at P14 (Figure 5.3.9 A-C) 
show that peak latencies and amplitudes of AN wave I and synchrony of AN firing 
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were not significantly different between the QKI-Ctrl and QKI-KO animals. The 
similar responses between the QKI-Ctrl and QKI-KO, the contrast with our 
findings in Group 1 P14 may be due to our results showing that the majority of 
P14 QKI-KO SGNs were densely myelinated throughout their axons (Figure 
5.3.3). We also showed that axo-glial connector protein Cntn1 was still present in 
the heminode and axonal paranodes in these P14 QKI-KO mice.   
 By P21, the responses between QKI-KO and QKI-Ctrl are more 
distinguishable (Figure 5.3.9 D-F). There is a trend towards increased wave I 
latencies and decreased AN firing synchrony in the QKI-KO mice compared to 
QKI-Ctrls. Peak amplitudes are distinguishably different. Although these results 
are not as striking compared to our physiological findings in P20 Group 1, 
eventual dysmyelination due to dysfunctional glial cells may still be implicated in 
AN functional declines. Together with our results shown in Figure 5.3.8, these 
findings highlight the importance of normal myelinogenesis and myelin 
maintenance for proper AN function. The structural and functional phenotypic 
differences between the QKI-KO groups also accentuates the critical time points 












Figure 5.3.9: Eventual dysmyelination due to qkI KO at peak myelination may 
lead to functional declines in later development 
 
Suprathreshold measurements of peak latency (A), mean PLV (B), and peak 
amplitude (C) show no difference between P14 QKI-KO and QKI-Ctrl. (n = 4 mice/8 
ears per group). Measurements between QKI-KO and QKI-Ctrl at P21 (D-F) shows 
a trend towards AN functional declines. (n = 3 mice/6 ears for QKI-KO, n = 5 











Through the work done in this chapter, we showed that primary glial 
dysfunction due to the qkI KO around the critical time period of myelination 
caused severe AN structural abnormalities pertaining to myelination and nodal 
formation. All three node types were affected by the glial dysfunction. We 
showed that Cntn1 was chronically ablated in all paranodes and our 
ultrastructural studies showing detachment of glial process/myelin from the SGN 
membrane or loose, non-compact myelin lamellae indicate that the axo-glial and 
glial-glial connections were either not present or were compromised after qkI 
knockout. Importantly, we showed that the ensuing dysmyelination and nodal 
structural malformation led to SNHL, as shown by slower conduction velocities 
and AN dyssynchrony in the mutated mice. Studies of PNS diseases, such as 
GBS and CMT indicate that nodal disruption65 and demyelination64,190 are 
associated with decreased nerve function leading to sensory loss and muscle 
weakness. Here, we show similar results occurring in the AN after primary glial 
dysfunction which greatly implies the importance of normally functioning glia.  
Our studies also showed that qkI is essential for myelinogenesis and 
subsequent myelin maintenance in the developing mouse AN. Knocking out qkI 
around the onset of myelination, before peak myelination occurs was enough to 
cause chronic glial dysfunction that resulted in widespread inhibition of 
myelinogenesis, as shown by the continued enwrapment of the fibers/cell bodies 
only by a single layer of thick glial cell process even after the time point of 
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hearing maturation (P20/21). Mature myelin is characterized by multiple, thin 
lamellae that are compactly stacked atop each other. The glial processes exude 
their cytoplasm as they proceed to enwrap the axons. Myelination of the SGNs 
never fully initiated in the hypomyelinated fibers and the AN response were 
chronically impaired as shown by our physiological studies of the P20 QKI-KO 
mice from the Group 1 – P5 induction. Our studies also show that 
myelinogenesis cannot be inhibited or reversed by the knockout of qkI at the 
peak of myelination. Rather, our P7 induction group emphasizes qkI’s importance 
for continued maintenance of myelination by AN glial cells. These Group 2 – P7 
induction animals had multi-layered, compact myelin at both P14 and P21. 
However, by P21, the eventual dysmyelination due to the dysregulation myelin 
maintenance is apparent by the loosening of the multi-layered myelin and 
detachment from the SGNs. In addition, Cntn1 expression, which was reduced, 
but still slightly present in Group 2 P14 QKI-KO, is completely lost in the P21 
QKI-KO paranodes.  The differing phenotypic outcomes between the pre-peak 
and peak myelination initiation of qkI/QKI-RBP deficiency demonstrate that qkI’s 
regulation of myelin formation and maintenance is developmental stage-
dependent.  
In the mouse AN, we knocked out the QKI-RBPs specifically in the AN 
glial cells, as the Plp1 promoter and the qkI gene were colocalized only in the AN 
glial cells. QKI-RBPs have more than a thousand QRE-containing putative 
downstream mRNA targets59,140, including the qkI gene itself191. In addition to 
mRNAs, the QKI-RBPs were shown to bind other forms of RNA that have the 
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QRE sequences. They were shown to target hundreds of circular RNAs, and 
were implicated in playing a role in circular RNA synthesis and regulation192. 
They were also shown to bind and affect processing of microRNAs193,194. We saw 
that different sets of QKI-RBPs targets were up-regulated in P3 and in P7, 
implying that the QKI-RBP targets in P3 are involved in myelinogenesis and the 
targets in P7 are involved in myelin maintenance. In order to more directly figure 
out what targets are being bound and affected by QKI-RBPs, in the AN, we could 
perform RNA-IP and sequence the resulting products. This would first give us a 
list of actual, present targets in the AN. We could also perform RNA-seq total 
RNAs from isolated samples from both Group 1 – P5 and Group 2 – P7 induction 
at both P14 and P20/21 to find which target genes are more or less affected by 
each induction group for both time points. Comparing target genes in P14 would 
be very valuable because it is at that time when the phenotypic differences 
between the two are greater, and this would indicate which genes are more 
involved in myelinogenesis. Comparing the target genes in P20/21 would also be 
good because dysmyelination is present in both QKI-KOs, indicating which genes 
are necessary for myelin maintenance.   
 Other important findings in this chapter include qkI KO-induced 
recruitment of macrophages and the pathological morphologies of the SGCs we 
saw, especially in the P5 qkI KO. Although SGN apoptosis may signal these 
macrophages, visual inspection of SGN numbers through our TEM and 
immunohistochemical studies indicate that SGN death in the QKI-KO mice were 
not rampant. SGN losses, at least in the middle turn where most of our studies 
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focused on, were not comparable to those seen in cochlea injured by ototoxic 
drugs195,196. Perhaps dysfunction of the glial cells were enough to cause active 
recruitment of macrophages.  
 The SGCs can be thought to the more plastic AN glial cell compared to 
their SC counterparts as they are shown to express Sox2, which is a marker of 
proliferation153, even in normal cochlea. KO of qkI seem to affect function and 
morphology of SGCs more than they do SCs, as dysmyelination around the 
somata were prevalent for both QKI-KO groups. We also found that Sox2 
expression was decreased at either endpoints of both QKI-KO groups compared 
to the QKI-Ctrls (Appendix A-2). This could indicate loss in plasticity. However, 
our ultrastructural studies also show that SGCs in QKI-KO take on a more 
globular shape and appear similar to activated macrophages. Earlier in Chapter 
3, we discussed the possibility of SGCs playing a role in inflammation and 
neuropathic pain. Here we showed that SGCs appear diseased or macrophage-
like after the QKI-KO. Perhaps, SGCs in the AN are playing a role in 
inflammation either directly, similar to the inflammatory response seen after direct 
SGC mutation in the trigeminal nerve113, or by producing inflammatory factors in 
response to fractalkine signaling after injury114. It would be interesting to compare 
the molecular characteristics of normal and QKI-KO SGCs to cochlear 
macrophages to see how AN SGCs are playing a role in inflammation. This could 
be performed through co-immunostaining analyses of macrophage/microglial 
markers with SGC markers. Single cell sequencing of cochlear macrophages and 
SGCs could also be an option.  
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 Taken together, our findings show that qkI is essential for AN structural 
development and maintenance and that primary glial dysfunction can lead to 
SNHL. Both qkI and the AN glial cells should be further studied as possible 























Chapter 6: Global discussion 
 
 
 The primary goal of these studies was to determine the importance of 
normal functioning AN glial cells for AN structural and functional development 
and maintenance. Formation and maintenance of myelin and the nodal 
structures, along with providing trophic support for the SGNs and clearance of 
debris, are the main functions of SCs and SGCs in the AN. Much of these 
functions require the interaction of AN glial cells with SGNs. Aside from hair cell 
and cochlear lateral wall abnormalities, SGN pathologies, including synaptopathy 
and SGN loss due to injury via noise or ototoxic drugs are thought to be the 
primary cause of the “neural” part of SNHL. Compared to the research dedicated 
to SGNs, not much work has been done to elucidate the importance of cochlear 
glial cells to the AN.   
 The best way to determine the importance of the AN glial cells was to 
induce their dysfunction. But first, we needed to characterize their role in AN 
development to elucidate their importance for AN structure and function. One 
indirect measure of glial function besides myelination was to study the formation 
and maturation of excitable nodal domains and flanking paranodal structures. 
Proper axo-glial connections at the paranodal domain are required for clustering 
of VGSCs at the nodal gap and separating those VGSCs from the VGKCs of the 
juxtaparanode. Excitable nodal domains along myelinated sheaths are 
responsible for saltatory conduction. Direct measurements of myelination and 
nodal formation include physiological tests determining AN conduction and 
neural synchrony. As we could not perform single neuron recordings, we could 
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not determine the direct contribution of the excitable nodal domains to neuronal 
function. However, ABR measurements can give us information on AN latency, 
which corresponds to conduction velocity through the AN fibers, and the PLV 
across a presented number of trials, which can indicate the synchrony of fiber 
firing.  
 With our research in Chapter 3, we were one of the first in the field to 
characterize the three types of AN nodal domains and the differing myelin 
morphologies of the SCs and SGCs.  We also showed the importance of nodal 
structural maturation for AN functional maturation. Specifically, we determined 
that shortening of ganglion node lengths were associated with increases in AN 
wave I amplitude. We also showed that we were able to use the methods we 
developed/adapted and refined to study the nodal structures, and indirectly, glial 
function, for our subsequent studies. 
  One of the easiest ways to study AN injury and recovery is through noise 
exposure. Through our noise injury studies, we found glial dysfunction through 
the dysregulation of QKI-RBPs and their targets as contributors to the inability of 
the AN to recover its structure and function fully after high intensity noise 
exposure. We also determined the importance of qkI, a known regulator of 
myelination in other PNS systems for AN myelin and nodal structural 
maintenance. Our research with qkI dysregulation in response to noise injury led 
us to our subsequent studies of glial dysfunction and qkI dysregulation in the 
developing AN. Through this, we developed a method to study glial dysfunction 
in the developing AN through the KO of qkI in either pre-peak or at peak 
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myelination. As a result, we found that primary glial dysfunction during 
development leads to dysmyelination and loss of hearing function.  
 Besides forming and maintaining proper myelination and nodal formation 
for rapid saltatory conduction, one main argument for studying and finding ways 
to manipulate AN glial cells is for cochlear implantation. Cochlear implants work 
by directly stimulating the AN fibers to evoke responses63. If there are barely any 
AN fibers left, there would be nothing to stimulate. If dysmyelination is present in 
the remaining fibers excited by the implant, the ensuing response could be 
dyssynchronous or delayed, which further reduces the effect and value of that 
implant. There are also issues with cochlear inflammation due to trauma197 or 
intracochlear bleeding198 implantation which proceed to cause damage and 
fibrosis, reducing the effectiveness of the device. We discussed in Chapter 3 and 
5 the possible role of SGCs as a responder in the inflammatory response. This 
makes the SGCs a lucrative therapeutic target not only in relation to cochlear 
implantation, but also in the case of other AN inflammation, such as in noise 
injury. The fact that deletion of qkI in the AN glial cells produced a large 
inflammatory response also implicate qkI/QKI-RBPs and their targets as 
regulators of AN inflammation. Since we show that qkI deletion affects 
myelination and inflammation, researching possible gene therapies involving 








Chapter 7: Appendix 
 
 





A-1: ABR measurements after hearing onset  
A,B showed AN wave I threshold (A) and suprathreshold amplitude (B) 





















A-2: KO of qkI induced a chronic decrease of the Sox2 marker of plasticity in 
SGCs and increase of number of Iba1+ macrophages. 
KO of qkI at either time point lead to decreased Sox2 expression (green), as 
evidenced by decreased intensity of anti-Sox2 reactivity in Group 1 P14/20 (D,J) 
and Group 2 P14/21 (P,V) compared to their respective controls (A,G and M,S). 
Morphology and location of the Sox2 staining indicate that Sox2 is localized in 
SGCs in the RC. The increased numbers of Iba1+ macrophages (red) at either 
endpoint for both groups (E,K and Q,W) compared to QKI-Ctrls (B,H and N,T) is 
also very much apparent. Representative images were taken at the RC for each 
group and both P14 and P20/21 endpoints are shown. Nuclei were counterstained 
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